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Abstract: 
Molecular dynamics simulations have proven to be a breakthrough approach in providing 
molecular structure and function details of biological macromolecules. The fact that molecular 
simulations can provide details of individual particle motions as a function of time, opens infinite 
possibilities of answering specific questions about a model system with atomistic and molecular 
precision, often more easily than experiments on the actual system. Instead of relying solely on 
experiments, molecular dynamics systems are based on empirical force fields that mimic molecular 
interactions over time. There has been increasing interest in utilizing the multiscale molecular 
dynamics (MD) approach to simulate the properties of biological macromolecules for meaningful 
applications in areas of nanotoxicity, nanotherapy, and nanomedicine.  
Recent advances in nanomedicine have led to the great development of several drug-delivery 
platforms for targeted delivery. Polymeric drug delivery systems are designed and applied to 
ameliorate undesirable properties of the drug agents such as hydrophobicity, poor targeting ability, 
and broad scale toxicity. However, rational structural design of polymeric nanocarrier is only based 
on theoretical investigation, that restraint by absence of real molecular-level details. So, MD 
approach is used to provide those desirable details which not feasible in experiments. In our work, 
models of three generations of anticancer nanocarriers polymer were developed and characterized 
using multiscale MD simulations. The results were compared to in vitro experimental results. 
Observations were analyzed and found to be in good agreement with experiments results on size 
and morphology changes. Details shown by our systems helped us discover the reasons for the 
different nanocarriers’ performances. Our results show the in silico methods that can be used to 
contribute to drug nanocarrier design optimization work. 
 
Claudins, are critical components in building tight junctions (TJs) which could form paracellular 
channels or barriers for physiological functions. Recently, 27 types of claudins have been classified 
based on different functions and characteristics, and they are becoming potential points in 
developing drug delivery systems and pathological studies. However, the architecture of claudin 
strand in TJs is still unclear thus impeding further study and applications. So, we use MD 
simulation approach to replicate self-assembly process and try to find out the potential construction 
models. In our work, claudin-1, -2, -5, and -15 monomer models were built by homology modeling 
and validated. Self-assembly processes of non-mutated and mutated claudins were conducted to 
reproduce the construction of claudin macromolecular strands. Four classified dimer models 
predicted by existing research were found to be reproduced in our molecular dynamics systems, 
and their number distributions were calculated. Our results first time showed the potential models 
for TJ architectures that can be a guidance for understanding TJs. 
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1. Introduction 
1.1 Objective 
Molecular dynamics (MD) simulations have emerged as a powerful approach to study physical 
motion of atoms and molecules as a function of time1. This approach can provide dynamical 
information about the system in atomic level detail, which is often not feasible via experiments2.  
Due to the inherent complexity of the biological system, computational methods have become 
increasingly popular to study biochemical systems including biocompatible polymers, drug-
delivery nanocarriers3, membrane proteins4, enzymes, nucleic acids5 among others. In recent times 
larger and more complex chemical systems are being investigated using MD due to availability of 
affordable and powerful computers.  
In this work, MD simulations have been employed to study two unique chemical and biological 
systems. In the first system, optimization of anticancer drug-delivery nanocarriers is investigated 
for Food and Drug administration (FDA) approved drug Doxorubicin6. In the second system, self-
assembly of Claudin which is a kind of membrane proteins responsible for the tight junctions 
between neighboring cells through the body7, is investigated to understand the molecular 
architecture of the ubiquitous tight junctions.  
It is well-understood that efficacy of a biocompatible polymeric nanocarrier relies on both the drug 
payload and the polymeric scaffold encapsulating the drug8. Different types of building blocks 
interact with drug molecules differently resulting highly variable physiochemical properties such 
as size distribution, shape, targeting specificity, and stability9. Small differences in molecular 
structure of building block can potentially have significant effect on drug-encapsulation and 
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micellization10. Therefore, examining the molecular interactions between drugs and polymeric 
scaffold is critical for nanocarrier design. In first chapter, self-assembly processes of three 
generations of linear-dendrimer copolymers with FDA approved drug doxorubicin are presented. 
Morphologies of nanocarriers formed in MD simulations were compared to the experimental data 
and the results are presented.   
In the second chapter, we examine the cis-interactions of claudin proteins in lipid membranes. In 
general, claudin family of proteins form tight junctions complexes in the space lining two 
neighboring epithelial or endothelial cells to regulate intercellular permeability in underlying 
tissue7, however the molecular origin of the architecture was not revealed clearly11. With better 
understanding of the relationship between structure and function of tight junctions, we will likely 
be more closer to find cures for diseases caused by the presence or absence of tight junctions, such 
as hepatitis C virus12, Alzheimer’s13 and Parkinson’s14. In order to understand the molecular 
architecture of the tight junctions, we adopted a systematic step-wise approach. To start monomeric 
structure of claudin, protein was built by homology modeling methods15 and validated using a 
variety of computational tools16. In the second step, the claudin monomers were embedded in lipid 
membrane and optimized to obtain equilibrated structures. In the following step, cis-assembly of 
claudin proteins over tens of microseconds was performed that led of oligomeric strand formation. 
Close analysis of the dimeric interface in the strands that consistently led to four unique dimeric 
interfaces. All four of these dimers have been reported in the literature. The direct agreement 
between experimental and simulation results validates our computational approach and is 
promising for the research currently underway in our group on this topic.  
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1.2 Molecular Dynamics Simulations  
Molecular dynamics simulations have been used in numerous studies to understand the physical 
basis of the structure and function in biological systems since the late 1970s1-2. To complement the 
experiments, atomistic models4 are created to mimic the real system that are then propagated in 
time to reveal molecular-level details of the system. The movement atoms and molecules are 
governed by the Newton's equation, and the interactions between bonded and non-bonded atoms 
provide by the underlying force field. Several force fields such as AMBER17, GLYCAM18, 
CHARMM19, and GROMOS19b have been developed to provide experimentally comparable 
structural properties in atomistic detail. In general, force field is defined as the sum of bonded and 
non-bonded interactions. Bonded interactions include bond-stretching, angle-bending, and 
dihedral terms, and non-bonded van der Waals interaction via the Lennard-Jones potential and 
electrostatic interactions using the Coulomb's law20. The reference value in bonded interaction 
determine the ideal structural relation among the atoms within one molecules and control the 
energetic terms. The non-bonded interaction considers the atoms overlap and dispersion and it is 
responsible for calculating the atomic repulsion and attraction among the different molecules. 
Based on force field and Newton’s equation, energy and potential was considered and positions 
and velocities would be calculated in each time step, and then atomistic models have ability to 
interact and move within a period of time. As all positions are calculated with in timescale, motion 
trajectories of atoms and molecules could be shown.2 
1.3 Coarse-grained model 
 
MD applications often face problems about time-scale and length-scale disparity between computational and 
experimental methods21. Larger time-scale and length-scale computational works could provide more 
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means to represent nature and would be great help to experimentation. As longer and more 
complicated system simulations are required, atomistic models become a somehow too luxury 
approach for computational works22. Since, all atom-atom interaction are being calculated during 
the period of time, the simulation times are largely limited by the volume and complexity of system. 
And more calculations within the system leads to burden on computational resources. Practically, 
atomistic models are usually limited to nanosecond scale simulation times and around 10 
nanometers system sizes which cannot meet the demands in current scientific study. 
In order to better bridge computational to experimental methods, an alternative approach to 
overcome limitations of atomistic simulations is to employ coarse-grained (CG) models23. CG 
models are derived from atomistic model where on an average of four heavy atoms are assigned 
to one bead, resulting in decrease the number of particles in the system. The reduced number of 
particles along with larger integration step size in CG simulations leads to increase in improved 
efficiency of CG simulation by three or more orders of magnitude. Although the CG model 
decreases the resolution of atom-atom interactions, thermodynamic and structural properties of 
molecules could be reproduced and compromised by force field in CG model. One of popular CG 
force field that is frequently used is the Martini force field. In this model, each CG model bead is 
assigned in four types of interaction of sites, polar (P), nonpolar (N), apolar (C), and charged (Q), 
and each type has four to five subtypes to include subtle differences in chemical properties such 
as hydrogen-bonding abilities and polarity23b, 24.  
With the development of parameterization, various CG model have been developed to represent 
similar geometries and properties as atomistic model to help build more realistic and complex 
systems, such as solvent, ions, phospholipids, ring particles, and antifreeze particles23b. Even 
though CG models remove some chemical and spatial resolution and apply modified kinetics to 
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these beads, it could provide same overall movements and interactions of molecules as atomistic 
models for longer time. Introduction of more mature CG models benefits current biological 
mechanisms study a lot. CG models have been widely used in lots of areas in last decades, like 
biomolecules simulation including lipid, enzyme, protein and etc. In summary, utilization of CG 
model is beneficial for exploring more complex system in a larger timescale. 
1.4 Application of MD  
MD simulation approach has been used to both nanocarriers’ design and membrane protein areas 
as same as the works in this thesis, and it has been proven to be capable to help experimentation. 
There are several examples listed as following.  
Molecular and atomistic level details in designing nanocarrier are hard to be tracked because of 
the complexity and sophistication in experimentation. And MD approach could help reveal more 
unfeasible details in experimentation that could help designing the anticancer nanocarriers. A fair 
number of molecular dynamics cases have been done previously. Sharon M. Loverde et al, used 
rational coarse grain models to study PEG–PCL copolymer performance on anticancer drug 
Taxol25. By adjusting ratio of PEG and PCL in computational ways, relationships among micelle 
morphology, hydrophilicity, diffusion, transfer energy and performance were built properly which 
the process is hard and resources-consuming in experimentation. Another example in MD 
application in drug nanocarrier is, Mengyao Zheng et al studied siRNA delivery efficiency of PEI 
which is the most widely used polyction for nucleic acid delivery and its triblock copolymer. In 
that work, atomistic details of self-assembly of polyplexes with siRNA versus pDNA was shown 
by molecular dynamics ways which is a blind spot in experimentation. By using synergic method 
with experimentation, they claimed a relationship between nitrogen to phosphate ration, toxicity 
and transfection efficiency26. Both these two examples show applications of MD simulations could 
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help nanocarrier design work in a meticulous way that make copolymer to be more easily modified 
and evaluated.  
MD simulations are also used to synergizes experimentation works explore the role of specific 
amino acid in protein folding process or biological functions. Most of experimentations use 
mutagens approach that compare the functions, morphologies, and functions between non-
mutated and mutated system27. However, complexity in experimentation lead to loss of atomic 
and molecular resolution. MD simulations could detect detailed macromolecular constructions, 
track the atomistic interaction and calculate energetics in the biological system that might help 
reveal biological mechanisms, which these works could not be achieved by experimentation 
work. Therefore, molecular dynamics computational approaches becomes increasingly important 
in biophysical and biological mechanism study. In claudin area, there has been some molecular 
dynamics studies in last 3 years. Bhavaniprasad Vipperlaa et al used molecular dynamics 
approach to study claudin-1 point mutations effect in HCV infection28. By comparing several 
mutant models with native models, they claimed the single mutants would have unnoticeable 
change while double mutants models would affect the protein structures which the observation 
matched experimental works. In the same year, they use the same approaches to clarify Lys65 in 
claudin-4 as the potential amino acid point to claudin-4-ephrin type-A receptor 2 binding29. 
As these examples shown above, molecular dynamics computational approaches could be used 
to study both nanocarrier and protein folding/assembly areas. And this thesis will use molecular 
dynamics computational approaches to help understanding self-assembly processes of polymeric 
nanocarriers and tight junction proteins. 
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2 Designing anticancer drug delivery nanocarriers  
2.1 Introduction  
Cancer has been the world’s most fatal problem for long periods. Over 10 million cases are 
diagnosed and millions of patients die every year, and this number is still ascending increasingly30. 
However, until now, although no perfect solution was invented to solve this problem, better 
understanding of cancer mechanism, higher medical technology and mature treatment skills were 
performed to solve that problem31. In recent years, chemotherapy treatment is one of the most used 
approaches to therapy cancer due to its widespread treatment range, and various types of natural 
or synthesized drug were found to have great efforts for anticancer treatments31d, 32. Despite the 
great effort to kill cancer cells, they have defaults that obstruct the application such as 
hydrophobicity that cannot be easily delivered in body environment, poor target ability that would 
be wasted during being transported to other area, the toxicity that will cause damage to other good 
organisms33. For example, Doxorubicin (DOX) was a kind of the main stream FDA-approved 
anticancer drug on the market to be used frequently for leukaemia and lymphoma cancer 
treatment34. DOX has been testified to have excellent performance on anticancer treatment, but its 
poor cancer-targeting ability and poor intratumoral leads to higher dose usage and cause life-
threatening cardiotoxicity35. The adverse effect largely limits the dosage to be used thus the 
applications were restricted. Another widely used FDA-approved anticancer drug is Paclitaxel. It 
has been used in anticancer chemotherapy for ovarian, breast and lung, bladder and etc for more 
than ten years. However, hydrophobicity, low bioavailability and rapid drug resistance effect36 
obstruct the usage of Paclitaxel37. So, lots of effort has been devoted to develop nanotechnology 
to help improve efficiency and solve the defaults of those drugs.  
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Nanocarriers are nano-scale size material used for transport substances to the target places8b. It is 
commonly used in medicine area for cancer treatment. Because of it is biocompatible, small sized 
and designable, nanocarrier has become a potential method of solving the problems mentioned 
above. Several aspects are critical and challenging in determining nanocarriers’ performances such 
as stability, drug-loading capacity, size distribution, and target specificity38. In drug administration, 
drugs are usually be delivered by oral, injection, ophthalmic, infusion, or intramuscular39. So, 
nanocarriers are required to have ability to protect the effective compounds in both chemical and 
physical area such as acid environment, blood stream shear strength, and high pressure. Also, 
nanocarriers need to have a good drug-loading capacity that they can carry more active compounds 
within the same dose and have a better effect. Size distribution is another important part related to 
biodistribution properties. Generally smaller size nanocarriers could more easily penetrate and 
have a higher cell uptake rate. And narrow size distribution contributes to stable drug release ratio 
and design improvement work. Active drug compounds usually have poor target ability, and they 
will infuse in body environment without specificity which will result in great waste, resistance and 
toxicity. Well-designed nanocarrier could improve the drug in chemical and physical stability in 
body environment, effectiveness, efficiency and biocompatibility40.  
 
Figure 1 Structures of three genderations of Telodendrimer. Black parts: Polyethylene glycol 
(PEG); Red parts: Lysine; Blue parts: Cholic acid (CA); Green parts: Rhein (RH); Gold 
parts: link (LIN) 
G1: PEG
5k
-CA
8
 G2: PEG
5K
–RH
4
CA
4
 G3: PEG
5K
–CA
4
-LIN-RH
4
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Block copolymer is a promising way to be used as nanocarriers because its designability and 
diversity8a. Several functional building blocks are copolymerized together to solve the challenges 
discussed above. With the amphiphilic character of block copolymer, hydrophobic active 
compounds will be automatically self-assembled and encapsulated within the copolymers, which 
is also easy to produce. Our work is based on a novel poly (ethylene glycol) (PEG) linear-
dendrimeric amphiphilic block copolymer, PEG5kCA8, so-called telodendrimer(Telo) which is 
developed by Dr. Luo’s research group41. PEG5kCA8 telodendrimer is a linear copolymer built by 
112 polyethylene glycol (PEG), 7 lysine (LYS), and 8 cholic acid (CHOA) as shown in Fig1 and 
it has been claimed to have great performance as a nanocarrier for hydrophobic drug paclitaxel. It 
can enhance blood compatibility and accumulation ability at tumor based by its slightly negative 
charge micelle surface. Recently, in order to extend PEG5kCA8 Telo to be used on new drug 
doxorubicin, two new generations of telodedrimer were invented by replacing building blocks on 
the structural platform. Four CHOA were replaced by rhein (RHN), a short amphiphilic link (LIN) 
was added and building blocks were reorganized to second generation Telo PEG5KRh4CA4 and 
third generation Telo PEG5kCA4–LIN-Rh442. Luo’s group proposed introduction of rhein group 
will help self-assemble process with doxorubicin by pi-pi stacking and high binding energy. These 
two generations telodendrimer were validated to be able to self-assemble with doxorubicin and 
form micelles, the performances between these two generations telodendrimer were compared and 
discussed. The results showed that second generation telodendrimer has lower drug release ratio 
than that of third generation which is better in clinical use. Also, the shape of third generation 
telodendrimer micelle is predominately longer worm like shape that make size distribution wider 
while second generation telodendrimer micelle forms shorter worm like shape micelle. It was 
somehow out of their expectation that third generation Telo was expected to have more stable 
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interaction with doxorubicin because all binding rhein group in one side might provide more stable 
interactions, while in the second generation RHN building blocks are paired with CHOA that might 
have lower stable interaction.  
 
In order to further study drug delivery system and help explain the performance difference, 
computational approaches are here applied to explore the molecular details in nanocarrier 
assembly process. By using synergistic computational and experimental approaches, microcosmic 
situations can be revealed and tracked and those details can help reveal reasons why and how 
subtle changes in building block affect micelles function. In this work, we conducted CG-MD 
simulations based on Luo's two latest represents telodendrimer structure PEG5KRh4CA4 and 
PEG5kCA4–LIN-Rh4 and previous design PEG5kCA841-42. The interactions among two critical 
building blocks and drug within atomistic and CG models: rhein (RHN), cholic acid (CHOA) and 
doxorubincin (DOX) are simulated and compared to validate CG model representation. Also, in 
vitro self-assembly processes were reproduced and tracked by using our simulations. Three 
generations of telodendrimer were self-assembled with doxorubicin in water solvent within 20% 
drug encapsulation rate and micelle morphologies were compared. Several explanations based on 
MD simulations results were given to the different performance among these three generations of 
telodendrimer.  
  
In MD simulations, both atomistic model and CG models were used. Atomistic models were used 
to show the exact representations of each building block in molecules. CG models were derived 
from atomistic models, and they were used to simulate more complicated system for longer time. 
With the application of atomistic model and CG model, the multiscale MD simulations could show 
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chemical characteristics details of molecules as well as interactions among macro molecules. Our 
results showed consistency with real experimental results. And, our models were able to gives an 
insight for designing drug nanocarriers. 
 
2.2 System Preparation 
2.2.1 Coarse-grain model building 
Coarse grain model of building blocks in PEG5kRh4CA4 and PEG5kCA4 –LIN-Rh4 used in this 
thesis were kindly provided by Wenjuan Jiang shown in Fig 2. According to the valuated 
PEG5kCA8 model reported in previous study, 4 cholic acids building blocks were replaced by rhein 
in PEG5kRh4CA4 to adapt Doxorubincin(DOX). Then, an additional link was added to 
PEG5kRh4CA4 structure and building blocks were reorganized to build third generation PEG5kCA4 
–LIN-Rh4 shown in Fig3. Each coarse-grained bead was assigned into four main types of 
interaction sites: polar (P), nonpolar (N), apolar (C), and charged (Q). According to Martini force 
field, each particle type was represented in more accurate representation in 18 subtypes to show 
chemical nature such as hydrophilicity and hydrophobicity.  
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Figure 2 Coarse grain models of building blocks used in PEG5kCA8, PEG5kRh4CA4 and 
PEG5kCA4 –LIN-Rh4 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Coarse grain model of PEG5kCA8, PEG5kRh4CA4 and PEG5kCA4 –LIN-Rh4. 
Black parts: Polyethylene glycol (PEG); Red parts: Lysine; Blue parts: Cholic acid (CA); 
Green parts: Rhein (RH); Gold parts: link (LIN) 
PEG Cholic acid L-lysine Doxorubicin Rhein 
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2.3 Simulation Details 
2.3.1 Atomistic Benchmark Simulation 
Molecular dynamics simulations on the coarse-grained model were performed with GROMACS 
4.6.5 software package. 
To validate CG model, benchmark simulations were performed to determine the difference 
between atomistic and CG models. As Table 1 shown, in both atomistic system and CG system, 
18 of CHOA and RHN and DOX were randomly distributed in box filled with water initially. The 
reason only enabling CHOA and RHN rather than LYS and PEO interacted with DOX is that 
CHOA and RHN are the most critical drug attaching group with DOX, and their interaction 
performances would affect self-assembly directly.  
In atomistic model, each building block was randomly packed in a 6nm^3 size box with filled of 
atomistic water molecules initially. The initial system was conducted for 0.05 ns energy 
minimization by 50,000 steps of 0.001 ps under steepest descent minimization, 0.02 ns NVT by 
10,000 steps of 0.002 ps under Velocity rescale temperature coupling and 0.1 ns NPT by 50,000 
steps of 0.002 ps under Velocity rescale temperature coupling and Parrinello-Rahman pressure 
coupling. All bonds (even heavy atom-H bonds) were constrained in the equilibration works in 
NVT and NPT process and temperature in each process was set at 300K. After well equilibrated, 
MD were run for 280ns with no position restrain.  
In CG model, each building block was randomly packed in a 12nm^3 box with filled of CG model 
water. Standard MARTINI water involving 10% of anti-freeze water molecules (WF) was used 
here, which the WF beads are a little big than the normal CG water beads. The reason for adding 
antifreeze water is by using antifreeze water mole, will keep fluidity active and is more likely to 
real natural water molecules. The CG model systems were performed similar equlibration as 
14 
atomistic model while within larger time step and longer time. Energy minimization was 
performed for 2 ns by 50,000 steps of 0.040 ps under steepest descent minimization, 0.2 ns NVT 
by 10,000 steps of 0.020 ps under Velocity rescale temperature coupling and 1 ns NPT by 50,000 
steps of 0.020 ps under velocity rescale temperature coupling and Parrinello-Rahman pressure 
coupling. After equilibration, CG models were conducted MD without position restraint for 
1000ns. Both atomistic and CG models consider the periodical condition at xyz dimensions.  
System CHOA RHN DOX SOL Box size(nm) Time 
Atomistic 18 18 36 5557 6^3  280 ns 
CG 18 18 36 16555W+1835WF 12^3 1000 ns 
Table 1 Setup of benchmark system 
 
2.3.2 Coarse Grain Self-Assemble Simulation 
In order to replicate the self-assemble process as experimentation work, three CG molecular 
dynamic simulation systems were performed with each setup system shown in Table 2. In each 
system, 135 DOX and 614 Telo were randomly distributed in the system as Fig 4. The content ratio 
(ratio of drug loading) were around 23%, which is the ratio reported in Luo’s researh. The content 
ratios in three system is also very close so that wouldn’t affects our results due to ratio differnce 
even molecular weight of each generation telodendrimer was different. Then three systems were 
filled with standard MARTINI water molecules with 10% of antifreeze water molecule23b.  
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System DOX Telo W WF 
Drug 
Loading 
Box size 
setup(nm) 
PEG5KRH4CA4     240679 27035 23%   
PEG5K–CA4-LIN-RH4  135 614 287600 32970 23% 35 
PEG5KCA8     251792 27538 22%   
Table 2 Setup of self-assembly system 
 
         
(a) PEG5KCA8          (b)  PEG5KRH4CA4  (c)  PEG5K–CA4-LIN-RH4 
Figure 4 Initial setup of three system. In order for clarify, solvent is hidden in these three 
images for clearness 
 
Each system was first energy minimized by steepest decent algorithm for 2ns with 50,000 steps of 
0.04 ps time step in order to adjust every components in the system to a natural geometries and 
orientation.  
Two equilibration runs were performed after energy minimization.  
An isothermal−isochoric NVT equilibration (number of particles (N), system pressure (P) and 
temperature (T) were conserved) run for 1 ns with 50,000 steps of 0.02 ps coupling the system at 
300K based on energy minimized result structures. Temperature coupling was using velocity 
rescaling in a stochastic term. 
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An isothermal−isobaric NPT equilibration (number of particles (N), system pressure (P) and 
temperature (T) were conserved) based on NVT result structures, and run for 2 ns with 100,000 
steps of 0.02 ps coupling at P = 1 atm and T = 300 K. Temperature and pressure coupling was 
using velocity rescaling stochastic term and Berendsen algorithm barostat term, respectively. Two 
groups were assigned, one group was water molecules (WAT in .mdp file) and another group was 
Telo and DOX (MIC in .mdp file), to be coupled in separately thermostats and isotopically barostat. 
The non-bonded interactions terms were computed with the standard cutoff of 1.2 nm. Using the 
standard shift function, the LJ potential was shifted from r = 0.9 nm to the cutoff distance so that 
both the energy and force smoothly vanish at the cutoff value. 
After system was set up and equilibrated, CG model run molecular dynamics simulation for 3 μs 
at 0.02 ps step time. Coordinates, energy, and velocity trajectory files were saved at every 1, 0.1, 
and 0.2 nanosecond respectively.  
2.3 Analysis Approach 
2.3.1 Atomistic Benchmark Analysis 
Pi-Pi stacking is a kind of non-covalent interactions between aromatic ring structures43. Due to 
the opposite charge interfaces on two different aromatic rings, pi bonds are formed to be stacks. 
Pi-Pi stacking is a very important interaction in micelle formation because it relates to the 
morphology of micelle and drug-nanocarrier interaction. 
Because both DOX and RHN have aromatic ring structures. Pi-Pi stacking interaction occurred 
in three combinations of DOX+DOX, DOX+RHN, and RHN+RHN in the benchmark systems. 
They were visually seen and extracted from benchmark system results. Distance of Pi-Pi 
stackings were calculated by gromacs tool package g_dist and VMD 1.9.2 software distance 
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calculation. In CG models, since multiple heavy atoms were mapped to one bead, CG bead 2 on 
RHN and CG bead 2 on DOX which is close to center of plain were used to represent RHN and 
DOX plain. And the distances were calculated from Pi-Pi stacking configuration.  
2.3.2 CG Self-assembly Analysis 
In Self-assembly system, analysis in this sessions were using visual method.rames. Frames were 
extracted from the trajectory by using gromacs tool package trajconv. VMD 1.9.2 software were 
used track the trajectory of different groups. 
2.4 Results and Discussion 
2.4.1 Benchmark results 
In order to apply CG model to conduct long simulation, we need to validate our CG model could 
provide same behavior and characteristics as atomistic model. Fig 5 shows details of benchmark 
system results. In snapshots, CG models show same behavior as atomistic model that pi-pi stacking 
structures were observed in DOX and RHN, RHN and RHN and DOX and DOX combination but 
not in DOX+CHOA combination in both atomistic and CG model. This is because DOX and RHN 
share planar ring structures with similar chemical characters whereas CHOA barely shows 
aromatic rings for pi-pi stacking. Given this difference, instead of forming stacking, CHOA are 
more likely to either attach to the surface of DOX cluster or simply cross-link to DOX cluster. And 
RHN and DOX can form pi-pi stacking thus contributing more to build micelle. On the other hands, 
it needs to be mentioned that multi-layer Pi-Pi stacking occurs in DOX-DOX interactions in both 
atomistic and CG models. Although it is not possible for multilayer structure for single aromatic 
ring structures because once pi-pi stacking form, charge on aromatic ring structure will be 
neutralized to prevent stacking grow, however, there are two aromatic rings in DOX structure that 
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both of them can be receptor for Pi-Pi stacking and multilayer pi-pi stacking can form by rotating 
DOX. Here, by properly building CG model, it can show same behavior pattern as the atomistic 
model. 
 
 
Figure 5 Details of RHN+DOX+CHOA benchmark results. Purple parts: DOX Black parts: 
Polyethylene glycol (PEG); Red parts: Lysine; Blue parts: Cholic acid (CA); Green parts: 
Rhein (RH); Gold parts: link (LIN) 
 
 
Figure 6 Distance of Pi-Pi stacking of three combination in atomistic and CG model 
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In order to further testify CG model, distance of Pi-Pi stacking in CG and atomistic model were 
measured and compared, the results are shown as Fig 6. The Pi-Pi stacking distances in atomistic 
for DOX+RHN, DOX+DOX and RHN+RHN were 0.353 ± 0.025 nm, 0.355±0.020 nm, and 0.333 
± 0.083 nm, respectively, while Pi-Pi stacking distances in CG model for DOX+RHN, DOX+DOX 
and RHN+RHN were 0.3415 ± 0.118 nm, 0.445±0.080 nm, and 0.480 ± 0.113 nm, respectively. 
The distance of pi-pi stacking in both models do not correspond to each other since an average of 
4 heavy atoms are mapped to one bead that several coordinates are integrated together to make 
distance a little bigger. For that reason, CG model produces relatively longer distance of Pi-Pi 
stacking than atomistic model. Despite that, differences between corresponding CG and atomistic 
models keep constant, suggesting their similar performance in stacking which earns credit for CG 
model for modeling self-assemble process. It again proves that CG models’ Pi-Pi stacking could 
provide same functions except for distance that wouldn’t affect interaction.  
 
Figure 7 Number of hydrogen bond between DOX and RHN, and DOX and CHOA. Orange 
line: DOX and CHOA, Blue line: DOX and RHN 
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Hydrogen bond number between DOX+RHN, and DOX+CHOA in RHN+DOX+CHOA atomistic 
system were calculated and shown in Fig7. From the results, the number of hydrogen bond in both 
DOX+RHN and DOX+CHOA fluctuates within a small range which means both CHOA and RHN 
could interact stably with DOX. Specifically, D_C creates more hydrogen bonds than D_R, 
meaning that DOX and CHOA is more likely to interact by hydrogen bind rather than Pi-Pi 
stacking between DOX and RHN. This result also shows DOX interacting those two building 
blocks in different ways and preferences. 
 
2.4.2 Self-assemble process of telodendrimers-DOX systems 
In order to explore the different behavior patterns of telodendrimer-DOX interaction in 
PEG5KRH4CA4, PEG5K-CA4-LIN-RH4, PEG5K-CA8 systems and how different building blocks 
affect their self-assembly behavior, in vitro self-assembly processes were replicated as 
experimental works. Three systems were built within same number of telodendrimers and DOX 
whereas only difference among these three systems is the telodendrimer structures. All these three 
systems were randomly distributed initially and were set under same simulation environments.  
In PEG5KRH4CA4 system, the dynamic process of self-assembly is shown in Fig 8. From the serials 
of time-lapsed snapshots, DOX could be well encapsulated by telodendrimer and few DOX floats 
freely in the solvent at end of 3 microseconds. It has been clearly seen that, from 600ns, not only 
telodendrimer continued to capsulate DOX particles, but also the micelle pieces aggregate to form 
worm-like shape and later became a more complicated, branches structure. It drives attention that, 
the shape of micelle grows in several dimensions rather than simply elongating in one dimension. 
Massive branches were formed and physically crosslinked with each other to make the whole 
micelle thicker. At the end of 3 microseconds, three pieces of micelles were formed, that one big 
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branches worm-like shape and two short more spherical micelles. The simulation result matches 
the transmission electron microscopy image (TEM) in experimental data (Fig9e), showing the 
presence of both wormlike shape and spherical micelles. 
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Figure 8 Trajectory of PEG5K-CA4RH4 self-assembly process 
 
Figure 9 series images show the detailed construction of micelles in PEG5KRH4CA4 system at 3 
microseconds. By manually curtaining each group in system, the main core of micelle and 
aggregation situations can be clearly visualized and interpreted. The main core of micelle were 
built by DOX-DOX and DOX-RHN Pi-Pi stacking. As shown in figure 9d, up to 7 layers DOX 
Pi-Pi stacking was observed, constructing the domain of micelle core. Multi-layer Pi-Pi stacking 
makes the aggregation grow in one dimension, which is the main reason for the worm-like shape 
morphology. Another type of Pi-Pi stacking, T-shape Pi-Pi stacking which two aromatic ring 
structures are vertical to each other by favorable quadrupole, was observed frequently in Fig9. 
RHNs are forming T-shape stacking with DOX and help forming branches on the outside of DOX 
stacking micelle core as well as embedding in DOX stacking that help micelle core grow in one 
dimension. Moreover, from Fig9d, the branches were generally resulted from T-shape and 
sandwich Pi-Pi staking from DOX-DOX and DOX-RHN combination rather than crosslinking 
conditions from PEG chains.  
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Figure 9 Snapshots of detailed construction of PEG5KRH4CA4-DOX micelle, a. Micelle core 
without PEO; b. CHOA; c. RHN; d. DOX; e. TEM images; f. Whole micelle  
 
 
                 (a)  
               (b) 
 
                 (c)    
                (d) 
 
(e) 
 
                 (f) 
24 
In PEG5K-CA4-LIN-RH4 system, the dynamic process of self-assembly is shown in Fig 10. At the 
beginning of trajectory, similar self-assembly behavior was found as PEG5K-CA4RH4 system that 
micelle began to form. DOX was capsulated by PEG5K-CA4-LIN-RH4 and few free DOX 
molecules floating in system. However, this system shows some difference comparing to the 
PEG5K-CA4RH4 in each time frame. In serials of time frame, micelles aggregate more slowly than 
those in PEG5K-CA4RH4 system, and DOX stacking are more likely to exposed to outside without 
covering by RHN. Besides, at end of simulation, the PEG5K-CA4-LIN-RH4 system shows some 
linear micelle pieces without big branches were assembled rather than one big micelle with 
branches structure like PEG5K-CA4RH4 system. Comparing the TEM image in experimental data 
(Fig11e), there is a good agreement that both wormlike shape and spherical micelles exist while 
there are wormlike shape micelles than that of in PEG5KRH4CA4 system.  
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Figure 10 Trajectory of PEG5K-CA4-LIN-RH4 self-assembly process  
Figure 11 shows the detailed construction of micelle in PEG5K-CA4-LIN-RH4 system at 3 
microseconds. After hiding PEG chains, it is more obvious that there is less and smaller branches 
on the backbone comparing to the PEG5K-CA4RH4 system. Even the main backbone of micelle 
were built by DOX-DOX and DOX-RHN Pi-Pi stacking like PEG5KRH4CA4 system, it is also 
needed to be mentioned that DOX-DOX stacks were found being chopped by wider RHN-RHN 
stacks. No long multi-layer DOX Pi-Pi stacking like PEG5KRH4CA4 system was found in PEG5K-
CA4-LIN-RH4 system. In another words, micelle core of PEG5K-CA4-LIN-RH4 shows more 
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2400ns 
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            (f) 
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discontinuous than PEG5K-CA4RH4 system. Instead of RHN forms T-shape Pi-Pi stacking with 
DOX, RHN will more likely to aggregate with RHN and insert to DOX stacks.  
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Figure 11 Snapshots of PEG5K-CA4-LIN-RH4 telodendrimers at time t=3µs.  a. Micelle 
core without PEO; b. Choa; c. RHN; d. DOX; e. TEM images; f. whole micelle 
 
In PEG5K-CA8 system, the dynamic process of self-assembly is shown in Figure 12. It shows very 
different self-assemble behavior that DOX were poorly capsulated by Telodendrimer. Even 
spherical micelles were formed, the micelles were not stable at all during the simulations that the 
morphologies were keep changing. In spite of all DOX capsulated, PEG5K-CA8 system shows 
smallest spherical micelles among three systems. Micelles were very short and no clear wormlike 
shape was built. Also, in some micelles, micelle core DOX were unevenly exposed to outside 
environment. CHOA did attach to the DOX stacks by hydrogen bonds, but they were less likely to 
make any effort to form micelle and build branches. This result shows agreement with the 
experimental results that PEG5K-CA8 would precipitated within self-assembly with DOX. 
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Figure 12. Trajectory of PEG5K-CA8 self-assembly process  
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Comparing these three systems mentioned above, some molecular and atomistic details which are 
not feasible in experiments are shown in computational way. Difference in micelle entire 
morphology and micelle core forming details were discussed above. According to the benchmark 
results, it is shown that RHN and CHOA share different interaction way with DOX. RHN is able to 
form Pi-Pi stacking with DOX which interaction is more stable than simple attaching driven by 
hydrogen bonds. Different interaction pattern result in different performance between PEG5K-CA8 
and other two generations of RHN containing telodendrimer that PEG5K-CA8 would not form a 
stable micelle with DOX because CHOA would not help DOX micelle core grow, while two 
generations of RHN containing telodendrimer would. Difference in PEG5K-CA4RH4 and PEG5K-
CA4-LIN-RH4 were also discussed that PEG5K-CA4RH4 forms more big branches than the PEG5K-
CA4-LIN-RH4. This phenomenon could be explained by the chemical structure. Although both 
structures have same number of RHN and CHOA, their location in structure leads to the behavior 
difference. In PEG5KRH4CA4, pairs of RHN and CHOA were located on LYS branches and all four 
RHN were separated by CHOA. It was mentioned previously that Pi-Pi stacking could occur in 
RHN-RHN combination. So, CHOA in the structure performs segmentation functions that prevents 
RHN forms Pi-Pi stacking with themselves. CHOA would not participate in stack, instead, it would 
control the number of RHN embedding into DOX-DOX Pi-Pi stacks. Therefore, paired RHN and 
CHOA can cover evenly over the DOX stacks which provides additional protection for drug from 
releasing from micelle. On the other hands, since RHN were separated and distributed evenly on 
the LYS branches, each of them has more chances to form Pi-Pi stacking with DOX that form 
branches in multiple directions on micelle core. When it comes to PEG5K-CA4-LIN-RH4 system, 
different situation happened. A link chain was added into the whole structure and RHN and CHOA 
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were reorganized. The RHN-CHOA pair in on LYS branches was changed to two RHN-RHN pairs 
and two CHOA-CHOA pairs and four RHN and four CHOA were separated by linker. Without 
physical segmentation of CHOA, RHN pairs are more possible to form Pi-Pi stacking by themselves 
first rather than forming Pi-Pi stacking with DOX stacks. Then when the entire RHN-RHN stacks 
embedded into DOX stacks micelle core, they can only help micelle core grow in one dimension. 
With less help of RHN, branches are less observed in PEG5K-CA4-LIN-RH4 system and micelles 
would grow longer in one dimension. This rational explanation could help interpret why longer 
micelles are form in PEG5K-CA4-LIN-RH4 system. Besides, the longer linear micelle will lead to 
fragile micelle construction because it would bear more force in the middle point and more possible 
to break in middle, therefore leading to high drug release ratio.  
 
2.5 Conclusion 
Understanding nanoparticles’ self-assemble process is crucial to determine characteristics of 
micelles, and MD simulation is able to provide some explicit details that benefits us for optimizing 
drug nanocarriers. In this thesis, long time scale molecular dynamics approach with coarse grain 
model was used to replicate real self-assemble process and match experimental data. 
Three systems were simulated, explored and discussed in this project. Both PEG5K-CA4-LIN-RH4 
and PEG5K-CA4-LIN-RH4 could form wormlike shape and spherical with DOX while PEG5K-CA8 
could not. PEG5K-CA4-LIN-RH4 system shows most complicated structure with branches, PEG5K-
CA4-LIN-RH4 system show more long micelle pieces with less branches. All these three system 
begin with random system with same number of Telodendrimer and DOX. Morphology results 
show consistency with Luo’s research. It’s clear that different construction of RHN groups in 
telodendrimer structure facilitate different interaction with DOX. Segmentation of RHN would 
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probably help micelle core grow in multiple direction and form more complicated micelle 
morphology.  
3 Molecular architecture of tight junction proteins  
3.1 Molecular architecture of tight junction proteins 
Tight junctions (TJs), are multimolecular complexes constituted by intramembrane particles 
strands and fibrils associating the areas of two cells that regulate permeability of epithelia44. In 
1972, Fromter and Diamond found whether the epithelia is leaky or barrier is dependent on the 
intercellular tissue at adjacent area of two cells which then so-called as “tight junction” (TJ)45. TJs 
can function as selective barriers, ion channels and fence based on the different protein complex 
compositions. Also, TJs have multiple functions such as stabilizing cells together, maintain the 
polarity of cells, preventing/transporting passage of molecules and ions, and etc44a, 46. With the 
understanding of function and architecture of TJs, challenges in intricate disease such as 
Alzheimer’s13, Parkinson’s14 and hepatitis C virus12 are expected to more likely be solved.  
Claudin, is a critical components in TJs, named from the Latin claudere means “close”, first found 
and defined by Mikio Furuse and Shoichiro Tsukita in 199847. Currently, within more than 40 kinds 
of proteins classified in TJs, such as occluding, actin, claudin, zona occludins, and junction 
adhesion molecules, claudins family transmembrane protein are proven to be vital compositions 
to determine the paracellular permeability in TJs46, 50.With decades of study, 27 type of mammalian 
claudin has been found and classified which are expressed in all known epithelial tissues as 
epidermis, eye, cochlea, retinal pigment epithelium, exocrine pancreas and urinary bladder48. 
Claudin is a kind of small protein with molecular masses of 21-34 kDa, and its general structure 
contains four transmembrane domains (TM1-TM4), two extracellular loops (ECL1 and ECL2), an 
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intracellular NH2 terminus and an intracellular COOH terminus49. Claudins establish linear 
macromolecular strands with in TJ and provide a molecular seal to connect cells47. Existing 
experimental works have proven there are two modes cis- and trans- for claudin to interact and 
aggregate to be a macromolecular strands in TJs49. Cis- interaction means claudins are interacted 
within in the same membrane of a single cells and trans- interaction means claudins are interacted 
across two cells. Both two interaction modes are important for claudin to function as barriers or 
channels, but limited existing work could give explicit resolution of architecture-function 
relationship.  
Currently, with the release of crystal structure of claudin-15 and claudin -19, structural study for 
claudin macromolecular strand began to flourish51. Through isolation of multi-order oligomers and 
mutation works, some potential models of macromolecular strands were predicted. There are many 
evidence from biochemical, molecular biology, cell biology area showing the claudins’ functions 
are replied on their secondary and quaternary structure. For instances, Yu et al found the 
permeability of claudin-2 was based on ECL1 part, and mutating claudin-2 negative charged D65 
on the ECL part will result in cation ion permeability decreased on MDCK I cells46, 52. Piontek J 
found ECL2 on claudin-5 plays an important role in trans- claudin-claudin interaction that aromatic 
residue F147, Y148, Y158 will perform a strong binding core53. Hiroshi Suzuki et al reported a 
dimer width strand model for homo claudin macromolecular strand, and it is constructed mainly 
by two dimer types which are mediated by ECL β-sheet domain and TM domain54.  
Although cis- and trans- interactions for types of claudins are studied and some intelligent models 
were built, those predicted models are based on simple homo- interaction that are not accurate to 
show the complexity of real claudin strand. They claimed claudin strand formations are mainly 
based on and resulted from one or two dimer types that made the models nearly uniform11, 51, 55. 
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More complicated models constructed above two dimer types were not feasibly touched by 
experimentations, since it is too hard to isolate entire strand in TJs. 
Here we use in silico molecular dynamic simulation method to study the architectures of 
macromolecular claudin strands. Two channel forming claudin-2, and -15 and two barrier forming 
claudin -1 and -15 was selected to be studied. Even those four types of claudin share highly 
conserved residues and similar structures56, they located and functionalize differently in human 
body. We hypothesize that there are some relationships between strand structures and their 
functions.  
 
Figure 13 Sequence alignment of Human Claudin-1, -2, -5, -15, and Mouse Claudin-15. 
Sequence similarity is shown as blue. 
 
A comprehensive study to construction of these claudin strand were built and process of claudin 
homo cis-interactions were simulated. In our simulations, claudin-1, -2, -15 were built carefully 
by homology modeling15 according to the crystal structure of mammalian claudin-1551. Claudin-5 
monomer structure is borrowed from lab member FJ Irudayanathan’s work57. All three homology 
modeling results are validated by Ramachandran16a plot and Z-score16b. Four claudin structures 
testified by 100 ns atomistic level MD simulations, and they are proven to be stable and accurate 
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to applied long term MD simulations. But, the atomistic models are too computational expensive. 
CG models were introduced to improve simulation efficiency within acceptable accuracy. Self-
assembly simulations are began with 64 monomer grid with random interfaces, and at the end of 
simulation, they aggregated into long strands which are comparable to freeze fracture images from 
experiments. Also, four representative dimer types were reproduced in our systems that show 
excellent agreements with models predicted by experiments51, 55, 58. Moreover, cluster analysis, 
dimer distribution and probability density map of each dimer type was performed to show the 
difference in strand formation processes among four claudins. Our results show classified Dimer 
A and Dimer C is predominately found in all systems that make most contribution to form the 
macromolecular strand backbone. We also find Dimer B are specially formed in barrier forming 
claudin, claudin-1 and claudin-5 rather than pore forming claudin, claudin -2, -15. It is also showed 
only Dimer B decreased after two amino acid mutation work, which can be seen as a potential 
dimer type in claudin-5 strand formations.   
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3.2 System Preparation 
3.2.1 Homology Modeling 
Homology modeling is a technique of constructing 3D atom resolution protein structure of 
targeting sequence according to the empirically determined structure of homologues protein. Since 
amino acid sequence determine the secondary structure, by align sequence with homologous 
protein, targeting protein structural model could be produced. 
Claudin-5 structure was borrowed from FJ Irudayanathan’s previous work57 which has been 
properly prepared in homology modeling. The sequence of claudin-1, -2, -15 were downloaded 
from Protein Data Bank CLD1_Human (PDB ID: O95832), CLD2_Human(PDB ID: P57739), 
CLD15_Human(PDB ID: P56746) in the Protein Data Bank. Mutated claudin-5 sequence was 
manually revised based on claudin-5 sequence (PDB IDO00501). 
Several severs were used for homology modeling. I-TASSER59 (http://zhanglab.ccmb.med. 
umich.edu/I-TASSER/) and PHYRE260 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi? 
id=index) server was used to produce potential structure of claudin-1, -2, -15. In order to further 
refine claudin structure, four highest score structures of each claudin from I-TASSER and 
PHYRE2 server as well as crystal structure of mouse claudin-15 (PDB ID: 4P79) and Claudin-5 
from FJ Irudayanathan’s work were used as templates in homology modeling by Yasara Software.  
The structures from homology modeling were scored based on structure quality factor and 
membrane protein quality by using PROSA sever (https://prosa.services.came.sbg.ac.at/prosa.php) 
61 and RAMPAGE server (http://mordred.bioc.cam.ac.uk/~rapper/rampage.php) server. Those low 
score parts in structures were built by QUARK62 (http://zhanglab.ccmb.med.umich.edu/QUARK/) 
server and iteratively used as template to refine the structure. 
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3.2 Simulation details 
3.2.1 Atomistic Simulation 
Molecular dynamics simulations on the coarse-grained model were performed with GROMACS 
5.0 software package63.   
Qualified atomistic structure of claudin-1, -2, -5, and -15 monomers were oriented and 
hydrophobic thicknesses were calculated in PPM server (http://opm.phar.umich.edu/server.php).  
Molecular dynamics simulations on the atomistic model were based on CHARMM 36 force field. 
One claudin-1, -2, -15 monomer was embedded into POPC lipid molecules and surrounded by 
atomistic water and 0.15M KCL by using charmm sever (http://charmm-
gui.org/?doc=input/membrane). The systems were in periodical conditions. The monomer of each 
claudin was first energy minimized by steepest decent algorithm for 5000 steps, then serially 
equilibrated by NVT and NPT. After systems were well equilibrated, MD was performed in 
atomistic model for 1 microsecond with 50,000,000 steps of 0.02 ps coupling by at pressure 1 atm 
and temperature 310.15 K. Temperature and pressure coupling was based on Nose-Hoover 
algorithm and Parrinello-Rahman, respectively. Verlet cut-off scheme was used in all minimization 
and equilibration for it is faster and more accurate compared to group scheme.  
System Protein Number Lipid Membrane Time 
AA Claudin-1 1 POPC 100 ns 
AA Claudin-2 1 POPC 100 ns 
AA Claudin-15 1 POPC 100 ns 
Table 3 System setup for atomistic simulation 
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3.2.2 Coarse Grain Self-Assemble Simulation 
Average structure of each claudin monomer was extracted from trajectory. Since atomistic 
monomer’s shape was structurally changing during the MD process, structure from last frame will 
not be able to represent accurate monomer structure. Given the fact that C-terminal part cannot 
significantly affect claudin dimerization and strand formation except for diffusion coefficient due 
to lower overall mass, C-terminal residues beyond 195 were removed from the structures in order 
to reduce the box size in z-direction thus reducing the whole system volume and save 
computational efficiency. On the other hand, though C-terminal of laudin-1, -2, -5 and -15 starts 
at 185, 184, 181, and 183, respectively, the rest of C-terminals (~194) were not observed to have 
significant interaction during the MD simulations.  
In order to build a 8×8 monomer grid, averaged atomistic monomers were initially placed in a 4×4 
grid with inter center-of-mass distance of 6 nm using YASARA model software. Coarse grain 
model of each monomer in grid was built by MARTINI parameter set and its secondary structures 
was following ElNeDyn network. By using ElNeDyn network combined with coarse grained 
molecular force field, elasticity of protein scaffold can be well represented in molecular dynamics 
simulations. Insertion of protein in CG DOPC lipid bilayer was built by INSANE script. System 
was filled by MARTINI standard water molecules with 0.15M NaCl. Then the 4×4 grid was energy 
minimized for 0.5 ns with steepest decent algorithm and equilibrated by NVT and NPT for 100ns 
and 1000ns, respectively. Three groups were assigned in the index file. First group was water 
solvent and ions (“SOL” in .mdp file), second group is lipid (“LIP” in .mdp file) and third group 
was protein (“Protein” in .mdp file), to be coupled in separately thermostats and isotopically 
barostat. In NVT equilibration process, each groups were kept at 310K constantly with velocity 
rescale algorithm. In NPT equilibration process, semiisotropic pressure coupling was applied by 
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using parrinello-rahman algorithm, with a pressure of 1 atm. NVT and NPT process constrain all 
xyz dimensional position of each monomer. 
8×8 grid was built from 4×4 grid as unit by using the same approach to make 4×4 grid from 
monomer. 4×4 monomer grid was duplicated, moved and organized to generate an 8×8 monomer 
grid with 6nm inter center-of-mass distance. 8×8 grid systems only ran 0.5 ns of EM, 50 ns of 
NVT and 20ns of NPT for energy minimization and equilibration because all 4×4 monomer grid 
unit has been well prepared. In order to avoid configuration bias in dimerization, the 8×8 grid 
systems ran additional NPT process for 200 ns with position restrain on 87GLY backbone bead 
and z axis rather than entire position constrain to make random orientation on xy dimension. The 
reason to choose 87GLY backbone bead to be position restrained is that it is inner bead close to 
center axis of protein, thus relative position among each monomers would not be changed except 
for the orientation on xy dimension (Fig14).  
  
(a)            (b) 
Figure 14 Claudin-1 8×8 monomer grid. (a) 64 monomers within same orientations (b) 
represents all monomers with random orientations. 
 
After systems were set up and equilibrated, 8×8 grid system underwent molecular dynamics 
48 nm 
48 nm 
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simulation without positional restraints at 20 fs step time. Coordinates, energy, and velocity 
trajectory files were saved at every 0.5 nanosecond.  
64 monomer system setup was shown in Table 4. Each system was repeated under the same 
simulation environment. 
System Protein Number Lipid Membrane  Time*Repeat Times 
CG Claudin-1 64 DOPC 3 μs*2+5μs*1 
CG Claudin-2 64 DOPC 3 μs*2+5μs*1 
CG Claudin-5 64 DOPC 3 μs*9+5μs*1 
CG Claudin-15 64 DOPC 3 μs*2+5μs*1 
CG 
Mutated 
Claudin-5 
64 DOPC 3 μs*10 
   Total 97 μs 
Table 4 System setup for CG simulation 
3.3 Analysis Approach 
3.3.1 Reverse Mapping 
The coarse grained system from MARTINI were reverse mapped to atomistic system in 
CHARMM36 by using initram.sh script published by Wassenaar et al64. The reverse mapping 
process includes projection, energy minimization and serial position restrained NVT simulations. 
In our work, all CG models were energy minimized for above 0.2 ns and short MD of 0.02 ns with 
atomistic topologies. Proteins group was extracted from the system and monomers were reverse 
mapped for analysis. Solvent and lipids were hidden here for we focus on dimerization 
configuration here, 
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3.3.2 Monomer Analysis 
Structures resulted from Homology modeling were scored by structure predict server mentioned 
in section 3.2.1. Ramachandran plot and Z-score were used to validate the structure of claudin 
from homology modeling results. After short time atomistic simulation(mentioned in section 3.2.1),  
atomistic monomer structures were evaluated by root mean square deviation (RMSD), root-mean-
square fluctuation (RMSF), number of hydrogen bond (g_hbond) package tools in Gromacs. 
Donor-acceptor cut-off distance used in calculating H-Bonds were set as 3 Å. 
Root mean square deviation calculates the overall configurational change of protein structure 
according to the initial position during the time. Root mean square fluctuation calculates the 
flexibility of atomic positions in the trajectory during the time. Hydrogen bond is critical element 
to maintain the secondary structure, number of hydrogen bond can reflect the stability of secondary 
structure. 
3.3.3 Distribution of Dimer Type  
Counting dimer type approach was based on R programming which is a software widely used in 
bio-information area. A script to determine the dimer type was developed to count the each dimer 
type and details are attached in Appendix.  
Before counting the dimer type, four configurations of dimer were found and defined by published 
work51, 55b, 65. ‘*’ symbol is used to clarify a second monomer. Dimer A is formed from residues 
on ECL1 and ECL2*-TM3*-TM4* by opposite charges and hydrophobic-hydrophobic interaction. 
Dimer B is mainly mediated by TM3-TM3* interaction. Dimer C is mediated by residues on ECL2, 
TM3 and TM4 interaction. Dimer D is formed by an anti-parallel β-sheet arrangement of ECL-1 
residues. Configurations are shown as Fig15. 
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Figure 15. Configuration of Dimer. Blue segment TM1, green segment TM2, yellow segment 
TM3, red segment TM4. 
 
The script for determining these 4 types of dimer was built based on these models’ configuration. 
Several residues were picked to represent each TM part of claudin monomer as table 3 shown. 
Some residues were specifically picked according to the published work as criteria to specify dimer 
type.  
Criteria to select residue would be (1) They are conserved residue in all four claudins (2) They are 
located in the middle of each TM to avoid distance bias from tilt (3) They have similar in structural 
and chemical property. (4) Backbone Cα atom of each residue was picked  
  TM1   TM2   TM3   TM4   
Cld1 8-28 Leu16 82-102 Leu90 116-136 Leu127 164-184 Leu174 
Cld2 8-28 Leu16 82-102 Ile90 116-136 Ile126 163-183 Leu172 
Cld5 8-28 Leu16 82-102 Leu90 116-136 Leu126 160-180 Leu173 
Cld15 2-24 Leu17 75-99 Leu88 116-136 Leu126 160-182 Leu170 
Table 5 Topology and selected represent residues for each TM domain of claudin 
Dimer type is determined by the configuration of dimer models. Series of distance matrixes were 
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generated that TM-TM* distances and specific residue-residue* distances were calculated. 
Those which distance is below cutoff will be classified as “interacted” and above cutoff will be 
classified as “apart”. Cutoff parameterizations were built by more than five samples in each dimer 
configuration which are not shown in this thesis. Detailed cutoff parameterizations are shown in 
Appendix.  
Each dimer type is determined by following rules:  
Dimer A: TM1 and TM2 interface interacted with TM2* and TM3* interface, ECL1 interacted 
with part of TM4*; TM3 and TM4 interface is apart from TM3* and TM4* interface; Orientation 
of monomer and another monomer’s should be similar (standard deviation of (TM1-TM1*) and 
(TM2-TM2*) is lower than 10) 
Dimer B: TM3 interacted with TM3*, 138 TRP and 138 TRP* are interacted; TM1 is apart from 
TM1*, 147 PHE is apart from 147PHE* 
Dimer C: TM3 and TM4 interface interacted with TM3* and TM4* interface, 180 CYS and 180* 
CYS are interacted; TM1 is apart from TM1*, 138 TRP and 138TRP* are interacted, 147 PHE and 
147 PHE are interacted. 
Dimer D:  Residue 63-65 on β-sheet interacted with residue 63*-65* β-sheet by anti-parallel 
arrangement, 4th β-sheet is paralleled to 4th β-sheet*  
The TM-TM distance cutoffs for determining “interacted” were ranged from 0.2nm-0.24nm. The 
residue-residue distance cutoffs for determining “interacted” were ranged below 0.15nm. The 
cutoffs varies depend on the tilt conditions of claudin in lipid membrane. Those distances for 
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dimers tilting will have slightly more distance than those of dimers are vertical to lipid.  
3.3.4 Conformational Analysis 
Internal and external angle of dimer was calculated by R script and used to help explain dimer 
configuration. A script to determine the dimer Internal and external angle was developed by R to 
count the each dimer type and details are attached in Appendix.   
  
Figure 16 Representation of angle calculated in dimer 
 
Firstly, centers of mass of all monomers were calculated to represent location monomer. All 
monomers which center of mass distances between two monomers below 3.0nm are regarded as 
dimer. Secondly, four points within the dimer were selected in dimer for angle calculation, center 
of mass of TM1 and overall monomer of two monomers. Coordinates system is built upon center-
TM1 vector as positive y axis. Angle β and angle φ are calculated as Fig 16 shown. Angle β 
represents the external angle measuring the rotation of monomer B to monomer A and angle ϕ 
represents the internal angle of monomer B itself according to monomer A. The range of β and ϕ 
d 
Monomer A Monomer B 
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is (-180º, 180º) and (0º, 360º). Thirdly, angle β and angle ϕ plots are performed and visualized 
by kernel density estimation map to estimate the probability density function of angle distribution. 
  
3.3.5 Cluster analysis  
Cluster analysis was used to track cluster change during the trajectory at 20 ns intervals (50 frames) 
by gromacs tool package g_clustsize. Number of cluster and max cluster size was calculated at the 
cutoff distance at 0.5 nm. All monomers within distance 0.5 nm will be considered as a cluster.  
3.4 Visualization 
Visualization of the simulations trajectories were performed by Visual Molecular Dynamics 
Software 1.9.2 and YASARA model software suites. 
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3.5 Results and Discussion: 
3.5.1 Homology modeling of Claudin-1, -2, -15 
Human claudin-1, -2, -5 and -15 3D structure has not been solved and explored empirically by 
existing research. So, before conducting molecular dynamics simulation, we need to build 
monomeric structure by homology modeling based on homologues protein crystal structure. Here, 
we generated monomeric 3D structure of human claudin-1, -2, -15 based on the structure of murine 
claudin-15(PDB ID: 4P70) and previous work on claudin-5. The C-terminal domain and missing 
residues were modeled using ab initio method.  
After serials of refinement and remodeling, the final structure qualities were evaluated by 
ramachandran plot and Z-score in several severs, and results are shown in Fig 17. Both 
Ramachandran plot map and Z-score of protein structure quality are vital step to testify predicted 
protein structure. Ramachandran plot map considers the energy within the protein structures and 
shows the rational areas of backbone dihedral angles ψ against φ of amino acid in all existing 
protein structures. Claudin-1, -2, -15 shows 99.5%, 100%, 99.1% region agreed with the 
ramachandran plot respectively which means secondary structure within protein are overall 
energetically reasonable. The LEU108 in claudin-1, ARG197 and MET206 in claudin-15 was in 
outlier region. However, they wouldn’t take too much influence in our simulations because 
LEU108 is non-conserved amino acid in intracellular domain that make little effort to cis-
interaction and ARG197 and MET206 are the amino acid domains above 194 which were removed 
from structure will be discussed afterwards. Z-score map shows the qualities of overall structure 
of all experimentally determined protein structures in protein data bank. Overall structure Z-score 
was calculated by X-ray and NMR, and our Z-score for each claudin was in the either X-ray area 
or NMR area which means our homology modeling structures can be typically found for native 
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proteins of similar size. Claudin-5 model used here was borrowed from FJ Irudayanathan’s 
previous work which 99% agreement with Ramachandran plot and the predicted secondary 
structure. 
 
Claudin-1 
  
Claudin-2 
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Claudin-15 
 
 
Figure 17 Ramachandran plot and Z-score of Claudin-1, -2, -15.  
After all these three atomistic claudin structure from homology modeling were validated, they 
were inserted in DPPC lipid membrane and run in molecular dynamics simulations for 100ns 
without positional restraints. Root mean squared deviation (RMSD) of protein, root mean squared 
fluctuation (RMSF) and number of hydrogen bond were used to evaluate monomer stability. 
RMSD is a measurement of overall structural deviation comparing to the initial structure during 
whole trajectory, which can be seen as an indicator of conformation stability. If RMSD keeps 
fluctuating in a small range, then we can regard the conformation will not change too much and 
keep stable during a period of time. Instead of determine the whole structure stability, RMSF is a 
measurement of deviation of position among the atoms in a period of time which can reflect the 
flexibility region in the structure. The difference between RMSD and RMSF is that RMSD 
calculates average position change of overall proteins conformation over time, while RMSF 
calculates average position change of each atom/residue over time. Number of hydrogen bond is a 
critical measurement for testify stability of the secondary structure in the protein. Within a stable 
conformation, number of hydrogen bond should keep stable during the time, otherwise, fluctuation 
in number of hydrogen bonds means secondary structure is changing and unstable.  
In Fig17, orange line in RMSD of claudin-1 shows RMSD for 194 amino acid domain claudin-1 
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model, which C-terminal domain was cut off, kept at a good convergence around 3.5 Å with no 
obvious fluctuation. Comparing with full 211 amino acid domain claudin-1 model shown in blue 
line that have a 2 Å range fluctuating RMSD around 5 Å, 194 amino acid domain claudin-1 model 
has a more stable structure during the whole time period. The fluctuation in RMSD was supposed 
to be resulted from the C-terminal domain. This inference was again proved by RMSF results. 
From Fig17 RMSF of claudin-1, there were peak fluctuations at 32-47 residue around, 101-119 
residue around4 Å 7 Å and 190-211 residue around 11 Å, showing the part of ECL1 region, ICL 
and C-terminal part are highly flexible part in the simulation. Flexibility of C-terminal was 
speculated to result from the charged residue and phosphorylation sites. Although C-terminal of 
claudin make effort on trafficking to tight junction, protein degradation, PDZ-binding, and 
phosphorylation, there is no evidence on C-terminal will make effort on cis-interaction49, 66. 
Besides, removing C-terminal domain could help us reduce whole system volume on the z axis 
that improve the computational efficiency. From Fig17c, claudin-1 monomer forms 161±5 
hydrogen bonds with no significant fluctuation during 100ns, which means that the whole 
secondary structure was stable in this period of time. For those results mentioned above, it is 
reasonable to claim that 194 amino acid domain of claudin-1 is a well prepared and ideal atomistic 
monomer structure for the following molecular dynamics simulations. 
Same analysis approach was used to testify claudin-2 and -15. The results are shown in Fig17.  
With removal of amino acid above 195, claudin-2 RMSD was decreased to a lower level around 
4.5 Å and there is no significant fluctuation. Highest flexible regions were in ECL1, ICL, and C-
terminal domain, which is similar with claudin-1. The hydrogen bonds in claudin-2 was kept at 
160±7 during 100 ns. Claudin-15 194 amino acid domain RMSD was kept stable around 3.4 Å. 
Claudin-15 RMSF showed two peak in ECL1 domain aroung 37, and 56. These two obvious 
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flexible regions were found to consistent with published crystal structure of mouse claudin-1551 
that 33-40 domain’s secondary structure is not defined and 55-59 domain’s secondary structure is 
coil. Claudin-15 hydrogen bond was 166±3 during 100ns. Both claudin-2 and -15’s C-terminals 
showed high flexibility and were removed for the following molecular dynamics simulation as 
discussed before. 
As a consequence, our results show homology modeling results claudin-1, -2, -15 are properly 
built and the structures are reasonable and stable enough for following molecular dynamics. 
Besides, we also found 194 amino acid domain for these three types of claudin is an ideal model 
for improving computational efficiency without significant impacts. 
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 Figure 18 RMSD, RMSF and H-bond of claudin-1, -2, -15
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3.5.2 Validation lipid membrane composition 
In order to study homo cis-interaction process, a proper CG system environment is required to 
be built correctly. CG models of claudin were built from the validated atomistic structures and 
average structure during the last 30 ns of trajectory which RMSD showing no obvious 
fluctuation.  
To characterize if the membrane would affect claudins’ cis-interaction, claudin-1, -2, 15 were 
oriented by CHARMM server67, and hydrophobic thicknesses were calculated. Gibbs free 
energy was a parameter to represent stability of protein configuration which means the energy 
needed from unfolded state to native folded state under optimal conditions68. These four 
claudins’ Gibbs free energy were all below 0 around -50 kcal/mol that all this four structures 
weere all stable enough to be used as beginning structure. Tilt angle is the angle of helix long 
axis corresponding to the membrane orientation which is correspond to the minimum Gibbs 
free energy. As we see here, although claudin-15 showed higher average tilt angle than the 
other three, four tilt angle were overall kept in same level, so it will be the similar condition 
for them to behave in cis-interaction. 
 Depth/Hydrophobic Thickness(Å) ΔGtransfer (kcal/mol) Tilt angle 
Claudin-1 31.4 ± 1.8  -47.4 16.± 5.° 
Claudin-2 32.8 ± 3.1 -55.3 14.± 4.° 
Claudin-5 36.6 ± 3.6 -51.3 18.± 1.° 
Claudin-15 31.0 ± 1.5 -51.7 27.± 8.° 
Table 6 Hydrophobic Thickness and gibbs free energy of claudins 
In real world, biological membrane are very dynamic and complex with various sorts of 
composition. And hydrophobic thickness, phase behavior, area per lipid, volume and changes 
in lipid structural order resulted from the composition variance will play important roles in 
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self-assemble process for transmembrane proteins69. If the lipid membrane thickness was 
largely below the protein hydrophobic thickness, protein will be tilted more or squeezed to fit 
the membrane thickness thus increasing the whole potential energy of system. If the lipid 
membrane thickness was largely above the protein hydrophobic thickness, protein will be 
stretched to lose their secondary structures or will be over disordered and cross-linked70. Also, 
the phase behavior also need to be taken into consideration that should be dynamic enough to 
be used in our computational simulation. It would make no sense for those simulation if the 
lipid membrane is too much sticky or rigid that proteins cannot diffuse at all. So, for demand 
of accuracy and efficiency, selecting a proper lipid composition to be used in molecular 
dynamics simulation would be a very critical step. DOPC, 1,2-di-(9Z-octadecenoyl)-sn-
glycero-3-phosphocholine, was selected to be the lipid membrane composition which thickness 
of bilayer is measured by stomic-force microscopy (AFM) to be around 31 Å at the 36°C with 
low temperature of melting(TM) at -17°C71. The hydrophobic thickness is properly fit the range 
of all four claudins’ hydrophobic thickness. All four TM domains will not be tilted and 
squeezed too much that affects interaction among monomers. Low TM of DOPC make lipid 
membrane gel phase that protein can diffuse faster to improve computational efficiency without 
affecting cis-interaction.  
3.5.3 Cluster analysis 
Four types of claudin were conducted molecular dynamics simulation under same environment 
with random interfaces initially. Monomers began to interact with each other and aggregate to 
form macromolecular strands and Fig 19 shows 10 microseconds’ results. The morphology of 
macromolecular strands looks similar to claudin based macromolecular strands observed in the 
freeze fracture microscopy images.  
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Figure 19 Snapshots of claudin macromolecular strand in MD simulation at 5 
microsecond and freeze fracture image of Claudin-1 based macromolecular strand 
 
Cluster analysis was conducted to the trajectory of each claudin to explore the cluster behavior 
pattern. Largest size of cluster and number of cluster was tracked in first two microseconds 
because no significant change observed afterwards. The claudin monomer’s size on x and y 
axis is around 3 Å, and cut off to determine the cluster was set at 5 Å which means gap distance 
between two monomer below 2 Å would be define as interacted. The cutoff distance is kept 
consistent with FJ Irudayanathan’s work about center of mass distance of different monomer 
in dimer oligomerization. Three repeat simulations were performed under same environment 
with random monomer interface orientations. Largest size of cluster and number of cluster plots 
was taken average based on three repeat simulations. 
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Figure 20 Number of cluster during 2 microseconds 
 
The number of cluster shows change of number of cluster in system versus time. By tracking 
the number of cluster, difference in oligomerization speed could be shown. Claudin-1, -2, -5, -
15 clusters numbers began from 58, 59, 59, and 59 respectively (Fig20). The numbers were not 
64 because the interfaces were randomly oriented at the z axis of A87 backbone bead rather 
than center axis of monomer, thus some monomers’ center of mass distance might be be below 
5Å which was possible to be determined as interacted. But, since number of cluster of each 
cluster were very close at beginning and cutoffs were set as same, there would be little influence 
to see the difference of oligomerization speed during the whole trajectory. From the trajectory, 
all four claudins oligomerized in similar speed that interacted with each other and aggregate 
rapidly in the first 0.5 microsecond, then the speeds slowed down continuously. It is reasonable 
to understand the oligomerization process behavior that the larger cluster would diffuse slower 
because of the larger mass. Although at the end of 2 microseconds, claudin-1, -2 -5 and -15 
formed 8.00, 5.67, 4.67, 6.33 clusters on average respectively, the difference is so tiny that may 
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resulted from randomness of system. Overall, four types of claudin showed very similar cluster 
behavior pattern on oligomerization speed. 
 
Figure 21 Maximum monomer number in cluster  
 
The max cluster size shows maximum number of monomers aggregating into one cluster and 
it always shows the largest cluster. From the Fig20, Claudin-1, -2, -5, -15 began 
oligomerization at 2 monomer cluster which the reason has been mentioned before and formed 
17.00, 32.67, 30.33, 22.33 monomer clusters at end of two microseconds. The results were 
taken average by three repeat simulations. For the reason that oligomerization speed began to 
slow down largely at 0.5 microsecond and numbers of cluster of each claudin remaining 
extremely similar after 1.5 microsecond, it is meaningless to track max cluster number after 
1.5 microseconds because the huge change in max cluster size might because of aggregation 
by two middle size cluster in specific case. Therefore, although claudin-1 showed the smallest 
cluster by 17 monomer and claudin-2 formed 32.67 monomers cluster at the end of 2 
microseconds.   
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In summary, from the results shown above, four types of claudin showed similar behavior 
pattern in both number of cluster and max cluster size.  
 
3.5.4 Four classified dimer in simulation 
In order to explore the details of strands, four unique dimer interfaces which have been 
observed consistently in four systems were classified and labeled from A-D. The A-D dimers 
samples shown in this session were picked from the 5 microseconds’ simulation results. Dimer 
A and Dimer C was most observed in four systems. Dimer A is driven by both hydrophobic-
hydrophilic interaction and electrostatic interactions. For the hydrophobic-hydrophobic 
interaction, dimer A is driven by hydrophobic amino acid on small helix in ECL1 and TM3*-
ECL2* hydrophobic area. For electrostatic interaction, dimer A is formed by opposite charged 
amino acid on 4th β sheet on ECL1 domains and TM3*-ECL2*-TM4*. Snapshots of structure 
and contact map is shown as below. Although the interaction might be formed by various non-
conserved amino acid for different claudin types, since these amino acid could show similar 
chemical interaction, same dimer interface configurations were shown in different claudin 
strands. Configuration analyses based on sequence alignment (Fig 22) and dimer configuration 
are shown below.  
 
Figure 22 Sequence alignment of claudin-1, -2, -5, and -15. Grey highlight: Similarity, 
green highlight: positive, red highlight: negative  
57 
 
 
 
 
Figure 23 Detailed dimer structural analysis and contact area map of Dimer A 
Dimer A hydrophobic-hydrophobic interactions is formed by conservative mutations amino 
acid which has similar chemical characteristics in those four claudins.  Claudin-1, -2, -5 and 
-15 dimer A is formed between 70 LEU and 149PHE*-150TYR*, 70 LEU and 148PHE*-
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149TYR*, 70 VAL and 148PHE*-149TYR*, and 68MET and 147PHE*-148TYR*, 
respectively. It is also showed that claudin-1 Dimer A is formed by positive charged 65LYS 
interacted with negative charged 147GLU-150ASP-160GLU cap. Claudin-2 Dimer A, oppose 
to claudin-1 that negative charged 65ASP interacted with positive 141HIS-145ARG162-GLU. 
Claudin-5 Dimer A is formed by two pairs of salt bridges, positive charged 65LYS interacted 
with negative charged 146GLU-149ASP and positive charged 61HIS interacted with negative 
charged 159GLU. Claudin-15 Dimer A is formed by negative charged 64GLU interacted with 
144ARG. Although the interacted residues are not consistent, all four claudin ECL1 64-65 
residue would anchored same ECL2-TM3 region with opposite charged. Besides, dimer A 
configuration in this study show agreement with the predicted dimer model in mouse claudin-
15 crystal structure research that hydrophobic interaction between 68MET promoter and 
PHE146*-PHE147*-LEU157* promoter as well as some electrostatic interactions nearby 
would contribute to the dimer A configuration.  
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Figure 24 Detailed dimer structural analysis and contact area map of Dimer B 
Dimer B is mainly mediated by TM3. However, it is rarely found in claudin-2 and -15 while it 
is seldom found in claudin-1 strand and prevalently found in claudin-5 strand. Dimer B in 
claudin-1 was formed by pairs of leucine zipper between TM3 and TM3* domains and 
139TRP-139TRP Pi-Pi interactions. In Claudin-5 Dimer B, two monomers were dimerized by 
138TRP-138TRP and 127PHE-127PHE Pi-Pi interactions and pairs of leucine zipper between 
TM3 and TM3*. By these interaction, a hydrophobic interface was built and make interaction 
stable. Leucine zippers were also found in Dimer C of all four claudins. Although leucine 
zipper is only reported be observed in FJ Irudayanathan’s work that contribute to Dimer B and 
C configuration, it has been found to also contribute dimerization in erythropoietin, aquaporin, 
and discoidin domain family of receptor tyrosine kinases (DDR1 and DDR2). A high 
evolutionary conservation residues were found in these four TM domain protein means that it 
might play an important role in dimerization. These dimer B in two types of claudin were found 
to match predicted model in published paper that TM3 mediate the dimer B configuration. 
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Figure 25 Detailed dimer structural analysis and contact area map of Dimer C 
 
Dimer C is formed between TM3-ECL2-TM4 of two monomers. From four contact map, we 
are able to clearly see the closest area between two monomers is TM3-ECL2-TM4 part. This 
discovery keeps consistence with Yongfeng Gong et al’s results about hetero cis-interaction 
model of claudin-16, -19 that TM3, TM4 and ECL2 are critical in cis- and trans- interaction55b. 
Despite experimental predicted models were produced by using different types of claudin, the 
residues proven to be critical in dimer C configuration were found to be conserved residues in 
most claudin or have similar chemical characteristics that might happen in most claudins. In 
that paper, by using alanine-insertion mutagenesis approach, they discovered several mutation 
points on TM3, and TM4 of claudin-16, and -19 not TM1 and TM2 would cause interaction 
loss. In our simulation, Dimer C configuration is similar with the model predicted in Yongfeng 
Gong’s work. From the Fig 25, leucine zippers were found in all four types of claudin that 
might provide high binding affinity for dimer structures as discussed previously. Besides, two 
conserved residues CYS around 180 from TM4 could form cysteine-cysteine and hydrophilic-
hydrophobic interactions between two monomer in dimer C configuration. Cysteine, as 
considered as a special amino acid, its thiol group and hydroxyl groups could greatly stabilize 
the dimerization by interacted with hydrophobic and hydrophilic region close to it such as LEU, 
ILE, PHE, and SER in four claudins72. Besides these interactions found in all claudin dimer C 
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configuration, Pi-Pi interaction on ELC2 ECL2 that 149TYR and 148PHE formed pi-pi 
stacking with another 148PHE and 149TYP to stabilize the Dimer C type. Some non-conserved 
residue might also contribute to the dimer C configuration. In claudin-2, Pi-Pi interaction 
occurred between 183PHE on TM4 of two different monomers. In claudin-5, 128CYS might 
provide additional binding affinity by hydrophobic-hydrophobic interaction. In claudin-15, 130 
CYS might provide the same effect for dimer C configuration. 
 
 
 
Figure 26 Detailed dimer structural analysis and contact area map of Dimer D 
 
Dimer D configuration has been predicted by several research that claudin-1, -2, -3, and -15 
could form dimer by anti-parallel β-sheet arrangement of ECL-1 residues and it is the critical 
dimer configuration for the channel function. Here our systems showed same configurations 
with those researches. The interaction was mainly driven by pairs of hydrogen bonds. Moreover, 
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the 65CYS and some hydrophobic amino acid like ILE, VAL, PHE around the 4th β-sheet which 
may leaded to hydrophobic-hydrophobic interaction with the same interface of another 
monomer. On the other hands, dimer D type occurred multiple times in claudin-1 and -2 while 
not found in claudin-5 and -15 at 5 microseconds. Although it happened at 2 microseconds 
frame snapshot (not shown here), it disappeared afterwards in 5 microseconds frame snapshots 
for both claudin-5 and -15. After tracking the trajectory, Dimer D anti-parallel β-sheet 
arrangement was shifted. It is possible that Dimer D type is not stable for claudin-5 and -15 
that during the aggregation, thus interacted interfaces would change during MD simulations. 
FJ Irudayanathan’s previous work57 about claudin-5 cis-interaction also showed Dimer D type 
in claudin-5 would have lowest potential mean force which means the Dimer D interaction 
would be the least stable interaction among these four types of dimer.  
 
 
So far, from the interactions discussed above, we showed the potential residues for all dimer 
type configuration. Our simulation systems also showed excellent agreement with the models 
has been discovered and were able to reproduce all models from current existing experiments. 
Even some models were built from mutation work in experiments, these models are still far 
away from elaborate the self-assembly process, and construction of TJs. Our MD simulations 
were able to, on the side, show atomistic level details about claudin cis-interaction and could 
be used as an assistance to guide the experiments. 
 
3.5.5 Distribution of Dimer Type  
Even the fact similar cluster pattern as well as similar basic dimer unit in the macromolecular 
strand, different detailed construction of strand might contribute in different types of claudin 
strand formation. So, we calculated the distribution of each dimer type by both hard distance 
criteria and soft angle criteria mentioned in session 3.3.3 and 3.3.4 by using R programming 
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script. The determining R programming script was based on the distance matrix of TM distance 
and potential residues discussed in 3.5.4 session. The distributions of dimer type are shown as 
below. All distributions were taken average from three repeat simulations at the end of 3 
microseconds, and were shown in percentage rather than number because the sample sizes 
captured were different in different systems. The distribution of each dimer type is a very 
significant founding that current technology could not attach, and our work on counting first 
show the potential distribution. 
 
Figure 27 Distribution of four classified dimer type in claudin macromolecular strand 
 
Fig 27 shows the distribution under hard distance criteria, the dimer counted here is exact dimer 
configuration without any variant configuration. Dimer A shows 58.6% in all claudin system 
and dimer A type shows the highest portion 46%, 54.35%, and 71.11% in claudin-2, -5, and -
15, and second portion 33.33% in claudin-1. Dimer C, D is second and third number of dimer 
type counted in claudin-2, -5 and -15, while Dimer C is a little higher portion than dimer A in 
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claudin-1. This result is found to show agreement with one of the predicted dimer types in 
claudin-15 crystal structure. In that experimentation works, claudin strands were predicted as 
dimer width strand and were constructed by a pair of dimer A strand end to end. Dimer A was 
the unit to elongate the strand.  
  
66 
 
Figure 28 Probability density map of angle distribution in all four claudin systems. 
(a)Overall distribution (b) Claudin-1 distribution (c) Claudin-2 distribution (d) Claudin-
5 distribution (e) Claudin-15 distribution 
 
Since distributions above is based on hard distance criteria, it is hard to determine the variant 
of each dimer type and other unclassified dimer. So we used angle distribution to clarify all 
(a) (b) 
(c) 
(d) 
(e) 
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dimer configuration Fig 28 shows the probability density map of angle distribution. On the 
contrary of hard distance criteria, angle distribution could not calculate the exact distribution 
of each dimer configuration but could show distinct dimer configuration and probability of 
variant which is similar to those four classified dimer configuration. So, probability density 
map of angle distribution were synergized with dimer distribution by hard distance criteria to 
explicit construction of claudin strands. 
Dimer B, C and D is symmetric configuration so that they are shown in one spot area while 
dimer A which is asymmetric configuration is shown in two spot areas. It also needs to be 
mentioned that two variant was discussed in session 3.5.4 that dimer A could be driven by 
hydrophobic-hydrophobic interaction as well as electrostatic interaction by various residues 
nearbyβsheet in ECL1 domain. So, two spot areas were classified and used to represent dimer 
A configuration. As we shown in Fig 28, all high probability spot areas were classified in four 
classified dimer types and no obvious unclassified area occurred. Moreover, the probability 
keeps consistent with distribution in our hard distance criteria. All these probability density 
results validated our distribution calculated by hard distance criteria. 
 
Figure 29 Probability density map of angle distribution of pore forming and barrier 
forming claudin system. (a)Pore forming claudin (b) Barrier forming claudin 
 
On the other hand, Dimer B configuration is only found in barrier forming claudin as claudin-
1 and claudin-5 by hard distance criteria. Also, probability density map of angle distribution 
(a) (b) 
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show very low probability of dimer B configuration in barrier forming claudin. Moreover, 
dimer B configuration is unique in claudin-5 which was found to be the tie second highest 
dimer type in claudin-5 while was the least dimer type in claudin-1, and not shown in claudin-
2 and -15. This result show it is possible dimer B is one unique dimer type for claudin-5 strand 
formation rather than the other claudin. On the other hand, according to the binding energy 
analysis in FJ’s work, dimer B has the highest binding energy and dimer A shows the third 
highest binding energy among these four dimer types which means dimer B is energetic 
favorable configuration. But, it is found that dimer A was showed above two times more than 
dimer B. Furthermore, although four types of claudin share conserved residues to form leucine 
zipper and pi-pi interactions being able to form dimer B, pore forming claudin-2, and -15 shows 
few dimer B configuration. It is possible that the dimer configuration is driven by not only 
hydrophobic thickness but also the chemical characteristic of different lipid membrane 
composition. This result is expected to be studied further and proven by the future work. 
In summary, it is significant that our in silico approach first time shows the distribution and 
numbers of distinct dimer type in strand construction and could be a guidance for future 
experimental works. 
3.5.6 Mutation of Claudin-5  
According to Jan Rossa’s work65 on claudin-5, I142T and F139S mutation was conducted in 
claudin-5, and linear claudin-5 strand formation was affected in experiments. In order to find 
out if dimer B could contribute in claudin-5 strand formation process, two amino acid mutation 
work was performed to claudin-5 as same as the experiments. Claudin-5 was manually mutated 
in sequence and simulated by same protocols as non-mutated system. All environment 
parameters used in MD simulation were kept same as non-mutated system except for amino 
acid sequence.  For pursuing statistical significance, ten repeat works of both non-mutated 
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and mutated claudin-5 were done. Since both mutation amino acids are located on TM3 part, 
dimer A and dimer D is indirectly relevant to the mutation work so that change on dimer A and 
D is not discussed here. Both dimer B and C configurations are mediated by TM3, so that the 
change of dimer B and dimer C are emphasized here. All count number analyses are shown in 
Appendix. 
 
Figure 30 Distribution of dimer B type in non-mutated and mutated claudin-5 
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Figure 31 Probability density map of angle distribution of mutated and non-mutated 
claudin-5 system. (a)Pore forming claudin (b) Barrier forming claudin 
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From the Fig 28 shown, dimer A is the most predominate dimer type in claudin-5 strand in both 
non-mutated and mutated type. As these two amino acid mutation does not directly affect the 
dimer A configuration on both electrostatic and hydrophobic-hydrophobic interaction, 
decreasing on dimer A is probably resulted from the unstable binding affinity energy. The same 
condition was observed on dimer D that dimer D is not mediated by TM3 but increased by 
11.91% after mutation. Dimer B and dimer C are both mediated by TM3 thus two amino acid 
mutation work would directly affects the configuration. After ten repeat 3 microseconds’ work, 
dimer B decreased by 3.72% while dimer C increased by 0.9%. The number of total dimer B 
decreased from 16 to 10 while number of total dimer C increased from 20 to 21. Generally 
speaking, dimer C portion was kept in same level and dimer B portion decreased a little. 
Although change of dimer B portion is not obvious, it could be regarded as potential dimer 
type contributing strand formation because dimer B could be interface between two dimer A 
strands so that even small decrease would affect linear strand formation.  
 
Figure 32 Number of dimer B type in non-mutated and mutated claudin-5 
macromolecular strand 
 
Through mutation work, we again showed the predominate portion of dimer A in 
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macromolecular strand, and dimer B rather than dimer C could be potentially critical dimer 
type in claudin-5 strand formation. Both of these detailed structural founding is significant 
finding because we first showed the change of complicated dimer distribution and they are 
extremely hard to be obtained by experiments.  
3.5 Conclusion 
Claudin is one of the most important protein in TJ that control the intercellular flows. Due to 
the complexity of experiments, the intact construction of TJ is still not revealed clearly. 
Although some mutation work and high-end techniques provide valuable information to help 
uncover the basic construction of TJs, the detailed construction is still elusive because of 
technique limitation. In this study, we used multiscale MD simulations approach to give new 
perspectives on the cis- interactions of claudin-5 TJs and show detailed architecture of claudin-
5 TJs. 
In order to study construction of TJ, 8*8 monomer grid with random interface was built on 
DOPC lipid membrane. After series of simulations, our 8*8 monomer grid CG models 
reproduce four dimer types same with experiments which is majority in strand formation. After 
discussed in details, these four dimer types showed excellent agreement with configurations in 
experiments. Two R-programming scripts were developed to calculate and determine the 
change of distributions of four classified dimer in our work, and here we first demonstrate the 
distribution of each dimer type in four claudin strand. Dimer A, C, D is found in all four claudin 
systems. Dimer A is the highest portion dimer type in most of claudin, while Dimer B is only 
highly expressed in barrier forming claudin -1 and -5. Also, by replicating the mutation work 
according to experiments, we showed dimer B is the potential dimer type in forming claudin-
5 macromolecular strands. All these results could, on the side, provide a guidance to the 
experiments and an aid to further understand TJs and claudin monomers cis-interaction pattern. 
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4. Future work 
Although this thesis gave an insight of molecules behavior in both nanocarrier and claudins, 
there are still lots of works needed to be done to further explain them in future. Molecular 
dynamics and application of CG models have been validated to be a great way in helping 
explore biological and chemical mechanism. More accurate force fields and more complicated 
models were built and used to help boost experimentation efficiency. However, there is still a 
long way from using simulation to perfectly reproduce the real experimentation, such as time-
scale limitation and complexity limitation. 
For telodendrimer nanocarrier area, we have built mature CG models and reproduced in vitro 
self-assemble process of three generations telodendrimers and doxirubincin and showed details 
of self-assemble behaviors. In future, more complicated environment is going to be used to 
mimic in vivo drug release process. pH factors can be in imported to simulate the environment 
of tumor mass or intestines and stomach by adding more charged ions to the environment thus 
these models can help develop drug delivery targeting ability or physical and chemical 
properties in oral administration. Also, fluid models can be used to simulate our drug to find 
out different rheological behaviors among different drug delivery pathways like blood stream. 
Moreover, novel dendrimer structures can be developed by revising or exchanging building 
blocks on our mature models.  
For claudin area, four claudin models were built by homology modeling, four dimer types were 
classified and insight distribution models were given based on those classified models. 
However, limited research was done to find out the detailed constructions of TJs and structure-
function relationship of claudins. In future, based on distribution of each claudins, more 
mutation works could be simulated to find out the relations between strand formation and each 
dimer type. Moreover, trans- interaction model or other TJ components like ZO and occludins 
could be applied to study the ion channel mechanisms and construction of TJs. Another 
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direction could be that add specific kind of drugs to our model and simulate the mass transport 
process. After all, there are still lots of things about claudin waiting to be solved nowadays 
such as mechanisms, constructions, biological properties, behavior in vivo and etc. 
With higher requirements of atom level details in biological and chemical area, computational 
work has been increasingly needed and used to help provide insight and guidance to traditional 
experimentation. And with better understanding and application of MD simulation approach, 
great contribution would be provided to advance pharmaceutical, pathological and physiology 
areas. 
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5. Appendix 
Script for determining numbers of each dimer type 
Change pdb file to 7 colume format 
```{r} 
outcome_data <-
read.csv("C:/Users/xwang104/Dropbox/CLAUDIN_FAM/Xiaoyi/Dimer/cld15/csv/cld15_no
mut3_3usaa.csv",header = FALSE) 
 
A<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==17&outcome_data$
V2=="CA", select = c(V5, V6, V7)) #pick AA on TM1 
B<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==88&outcome_data$
V2=="CA", select = c(V5, V6, V7))#pick AA on TM2 
C<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==126&outcome_data$
V2=="CA", select = c(V5, V6, V7))#pick AA on TM3 
D<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==170&outcome_data$
V2=="CA", select = c(V5, V6, V7))#pick AA on TM4 
 
trp<-
subset(outcome_data,outcome_data$V3=="TRP"&outcome_data$V4==137&outcome_data$
V2=="CA", select = c(V5, V6, V7))#138 TRP mid TM3 
phe<-
subset(outcome_data,outcome_data$V3=="PHE"&outcome_data$V4==147&outcome_data$
V2=="CA", select = c(V5, V6, V7))#147 PHE top TM3 
cys<-
subset(outcome_data,outcome_data$V3=="CYS"&outcome_data$V4==180&outcome_data$
V2=="SG", select = c(V5, V6, V7))#183 CYS down TM4 
beta1<-
subset(outcome_data,outcome_data$V3=="ASN"&outcome_data$V4==61&outcome_data$
V2=="CA", select = c(V5, V6, V7))#mid 4beta sheet 
beta2<-
subset(outcome_data,outcome_data$V3=="CYS"&outcome_data$V4==62&outcome_data$
V2=="CA", select = c(V5, V6, V7))#mid 4beta sheet 
beta3<-
subset(outcome_data,outcome_data$V3=="TRP"&outcome_data$V4==63&outcome_data$
V2=="CA", select = c(V5, V6, V7))#mid 4beta sheet 
betahead<-
subset(outcome_data,outcome_data$V3=="GLY"&outcome_data$V4==58&outcome_data$
V2=="CA", select = c(V5, V6, V7))#head ECL1 4beta sheet 
betatail<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==69&outcome_data$
V2=="CA", select = c(V5, V6, V7))#tail ECL1 4beta sheet  
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``` 
 
Calculate distance between All TM1 and TM1 
```{r} 
i <- 1:64; j <- 1:64;  #8*8 grid, can be other number 
ni<- length(i); nj <- length(j)   
y11 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni){ 
  for (p in 1:nj){ 
  y11 [p, k] <- dist(rbind(A[k,1:3],A[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM1 and TM2 
```{r} 
y12 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni){ 
  for (p in 1:nj){ 
  y12 [p, k] <- dist(rbind(A[k,1:3],B[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM1 and TM3 
```{r} 
y13 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y13 [p, k] <- dist(rbind(A[k,1:3],C[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM1 and TM4 
```{r} 
y14 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y14 [p, k] <- dist(rbind(A[k,1:3],D[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM2 and TM2 
```{r} 
y22 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y22 [p, k] <- dist(rbind(B[k,1:3],B[p,1:3])) 
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  } 
} 
``` 
 
Calculate distance between All TM2 and TM3 
```{r} 
y23 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y23 [p, k] <- dist(rbind(B[k,1:3],C[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM2 and TM4 
```{r} 
y24 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y24 [p, k] <- dist(rbind(B[k,1:3],D[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM3 and TM3 
```{r} 
y33 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y33 [p, k] <- dist(rbind(C[k,1:3],C[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM3 and TM4 
```{r} 
y34 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y34 [p, k] <- dist(rbind(C[k,1:3],D[p,1:3])) 
  } 
} 
``` 
 
Calculate distance between All TM4 and TM4 
```{r} 
y44 <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  y44 [p, k] <- dist(rbind(D[k,1:3],D[p,1:3])) 
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  } 
} 
``` 
 
######for detailed amino acid  
```{r} 
#138Trp-Trp  interaction 
ytrp <- matrix(NA, nj, ni) 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  ytrp [p, k] <- dist(rbind(trp[k,1:3],trp[p,1:3])) 
  } 
} 
 
#146Phe-Phe distance 
yphe <- matrix(NA, nj, ni) 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  yphe [p, k] <- dist(rbind(phe[k,1:3],phe[p,1:3])) 
  } 
} 
 
#183Cys-Cys distance 
ycys <- matrix(NA, nj, ni) 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  ycys [p, k] <- dist(rbind(cys[k,1:3],cys[p,1:3])) 
  } 
} 
``` 
####for Dimer D 
````{r} 
######for 63GLN-65LYS interaction 
ybeta13 <- matrix(NA, nj, ni) 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  ybeta13 [p, k] <- dist(rbind(beta1[k,1:3],beta3[p,1:3])) 
  } 
} 
 
######for 64CYS-64CYS interaction 
```{r} 
ybeta22 <- matrix(NA, nj, ni) 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  ybeta22 [p, k] <- dist(rbind(beta2[k,1:3],beta2[p,1:3])) 
  } 
} 
 
######for 65LYS-63GLN interaction 
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ybeta31 <- matrix(NA, nj, ni) 
for (k in 1:ni) { 
  for (p in 1:nj){ 
  ybeta31 [p, k] <- dist(rbind(beta3[k,1:3],beta1[p,1:3])) 
  } 
} 
 
####for distance between two 4beta sheet head and tail 
ybetaht <- matrix(NA, nj, ni)  
for (k in 1:ni) { 
  for (p in 1:nj){ 
  ybetaht [p, k] <- dist(rbind(betahead[k,1:3],betatail[p,1:3])) 
  } 
} 
 
####stdev of (head,mid,tail)beta 
ybetasd <- matrix(NA, nj, ni) # initiate a matrix with nj rows and ni columns 
for (k in 1:ni) { 
  for (p in 1:nj){ 
   w<- c(ybetaht[p,k],ybeta22[p,k],ybetaht[k,p]) 
  ybetasd [p, k] <- sd(w) 
  } 
} 
``` 
 
```{r} 
#Dimer A 
#Criteria 
belowcut11A<-subset(y11>20&y11>0) 
belowcut14A<-subset(y14<24&y14>0) 
belowcut23A<-subset(y23<24&y23>0) 
belowcut33A<-subset(y33>20) 
 
#Orientation 
z12<-y11-y22 
z13<-y11-y33  
a<-subset(abs(z12)<10) 
b<-subset(abs(z13)<10) 
dimerA<-
which(belowcut14A==TRUE&belowcut23A==TRUE&belowcut33A==TRUE&belowcut11
A==TRUE&a==TRUE&b==TRUE, arr.ind = TRUE) 
``` 
 
```{r} 
#Dimer B 
#Criteria 
belowcut11B<-subset(y11>30) 
belowcut33B<-subset(y33<20&y33>0) 
belowcutpheB<-subset(yphe>14) 
belowcuttrpB<-subset(ytrp<13&ytrp>0) 
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dimerB<-
which(belowcut33B==TRUE&belowcut11B==TRUE&belowcutpheB==TRUE&belowcuttrp
B==TRUE, arr.ind = TRUE)  
``` 
 
```{r} 
#Dimer C 
#Criteria 
belowcut34C<-subset(y34<24&y34>0) 
belowcut11C<-subset(y11>20) 
belowcutcysC<-subset(ycys<17.5&ycys>5) 
belowcuttrpC<-subset(ytrp<21&ytrp>5) 
belowcutpheC<-subset(yphe<14) 
 
dimerC<-
(which(belowcutcysC==TRUE&belowcutpheC==TRUE&belowcut11C==TRUE&belowcut3
4C==TRUE, arr.ind = TRUE)) 
```` 
 
```{r} 
#Dimer D 
#Criteria 
belowcutbeta1<-subset(ybeta13<14&ybeta13>0) 
belowcutbeta2<-subset(ybeta22<14&ybeta22>0) 
belowcutbeta3<-subset(ybeta31<14&ybeta31>0) 
belowsd<-subset(ybetasd<10&ybetasd>0) 
dimerD<-
which(belowcutbeta1==TRUE&belowcutbeta2==TRUE&belowcutbeta3==TRUE&belowsd
==TRUE,arr.ind=TRUE) 
```` 
 
```{r} 
#remove repeat 
nA<-matrix(dimerA,nrow(dimerA)) 
nA1=t(apply(nA,1,sort)) 
nA2=unique(nA1) 
nB<-matrix(dimerB,nrow(dimerB)) 
nB1=t(apply(nB,1,sort)) 
nB2=unique(nB1) 
nC<-matrix(dimerC,nrow(dimerC)) 
nC1=t(apply(nC,1,sort)) 
nC2=unique(nC1) 
nD<-matrix(dimerD,nrow(dimerD)) 
nD1=t(apply(nD,1,sort)) 
nD2=unique(nD1) 
 
print(paste("A",nrow(nA2),"B",nrow(nB2),"C",nrow(nC2),"D",nrow(nD2))) ##final reuslts 
```` 
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Script to calculate external and internal angle within dimer  
setwd("C:/Users/lenovo/Dropbox/CLAUDIN_FAM/Xiaoyi/RprogrammingCode/angle/angle/
cld5/") 
files<-dir() 
for(m in files){ 
  outcome_data<-read.csv(m,header = FALSE) 
   
  #outcome_data <- 
read.csv("C:/Users/xwang104/Dropbox/CLAUDIN_FAM/Xiaoyi/10repeat/csv/nomut/cld5_n
omut6_3usaa.csv",header = FALSE)#from campus 
  #outcome_data <- 
read.csv("C:/Users/lenovo/Dropbox/CLAUDIN_FAM/Xiaoyi/10repeat/csv/nomut/cld5_nom
ut1_3usaa.csv",header = FALSE)#home 
  A<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==15&outcome_data$
V2=="CA", select = c(V5, V6)) #pick AA on TM1 
  B<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==90&outcome_data$
V2=="CA", select = c(V5, V6))#pick AA on TM2 
  C<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==126&outcome_data$
V2=="CA", select = c(V5, V6))#pick AA on TM3 
  D<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==173&outcome_data$
V2=="CA", select = c(V5, V6))#pick AA on TM4 
  beta2<-
subset(outcome_data,outcome_data$V3=="CYS"&outcome_data$V4==64&outcome_data$
V2=="CA", select = c(V5, V6, V7))#mid 4beta sheet 
  betahead<-
subset(outcome_data,outcome_data$V3=="GLY"&outcome_data$V4==60&outcome_data$
V2=="CA", select = c(V5, V6, V7))#head ECL1 4beta sheet 
  betatail<-
subset(outcome_data,outcome_data$V3=="LEU"&outcome_data$V4==71&outcome_data$
V2=="CA", select = c(V5, V6, V7))#tail ECL1 4beta sheet 
   
  center<-data.frame(subset((A+B+C+D)/4,select = c(V5,V6))) 
  plot(center,col="blue",pch=19,cex=2) 
  text(center+10,labels=as.character(1:64)) 
  rownames(center)=1:64 
   
  distmat<-data.matrix(dist(center)) 
  dimer<-subset(distmat<30&distmat>0) 
  dimerPair<-which(dimer==TRUE,arr.ind=TRUE) 
   
  i <- 1:64; j <- 1:64;  #8*8 grid, can be other number 
  ni<- length(i); nj <- length(j)   
   
  ybetaht <- matrix(NA, nj, ni)  
  for (k in 1:ni) { 
    for (p in 1:nj){ 
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      if (k==p){ 
        next 
      } 
      ybetaht [p, k] <- dist(rbind(betahead[k,1:3],betatail[p,1:3])) 
    } 
  } 
  belowcutbeta1<-subset(ybetaht<15&ybetaht>0) 
  dimerD1<-which(belowcutbeta1==TRUE,arr.ind = TRUE) 
   
  ybeta22 <- matrix(NA, nj, ni) 
  for (k in 1:ni) { 
    for (p in 1:nj){ 
      if (k==p){ 
        next 
      } 
      ybeta22 [p, k] <- dist(rbind(beta2[k,1:3],beta2[p,1:3])) 
    } 
  } 
  belowcutbeta2<-subset(ybeta22<15&ybeta22>0) 
  dimerD2<-which(belowcutbeta2==TRUE,arr.ind=TRUE) 
   
   
  n<-matrix(rbind(dimerPair,dimerD2,dimerD1),nrow(rbind(dimerPair,dimerD1,dimerD2))) 
  n1=t(apply(n,1,sort)) 
  n2=unique(n1) 
  n3=n2[ , c(2,1)] 
  n4=rbind(n2,n3) 
   
   
  e<-1:nrow(n4);f<-1:2  
  ne<-length(e);nf<-length(f) 
   
  anglematrix<-matrix(NA,ne,5) 
   
  for (h in 1:ne){ 
    a=n4[h,1] 
    b=n4[h,2] 
     
    c1=center[a,] 
    c2=center[b,] 
    t1=A[a,c(1:2)] 
    t2=A[b,c(1:2)] 
     
    ##angle for beta in mol A range (-180,180) 
    v1a=t1-c1 #vector c1t1 not use 
    v2a=c2-c1 #vector c1c2 
    v3a=c(v1a[1,2],-v1a[1,1]) #vector verticle to c1t1 in clockwise rotation 
    a2=atan2(((v3a[1]*v2a[1,2])-
(v3a[2]*v2a[1,1])),((v3a[1]*v2a[1,1])+(v3a[2]*v2a[1,2])))*180/pi #beta clockwise  Vector 
OX to C1C2 use 
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    #angle for fi in mol B (0,360) 
    v1b=t2-c2 #vector c2t2 
    v2b=c1-c2 #vector c2c1 
    b1=atan2(((v1b[1,1]*v2b[1,2])-
(v1b[1,2]*v2b[1,1])),((v1b[1,1]*v2b[1,1])+(v1b[1,2]*v2b[1,2])))*180/pi #fi 
     
    if (b1<0) { 
      b1=360+b1 
    } 
     
    anglematrix[h,1]=a 
    anglematrix[h,2]=b 
    anglematrix[h,3]<-distmat[a,b] 
    anglematrix[h,4]<-a2 
    anglematrix[h,5]<-b1 
  } 
  plot(anglematrix[,4:5]) 
   
  test<-kmeans(anglematrix[,4:5],centers = 5) 
  plot(anglematrix[,4:5], col = test$cluster,pch=19,cex=1) 
   
   
  outputfilepath<-"C:/Users/lenovo/Dropbox/CLAUDIN_FAM/Xiaoyi/angledistribution3/" 
  #print(anglematrix[,4:5]) 
  write.csv(anglematrix,paste(outputfilepath,m,".csv",sep="")) 
   
} 
 
Dimer type count and percentage calculation from 3 repeat self-assembly 
simulations 
 
claudin-1 
Dimer 
A 
Dimer 
B 
Dimer 
C 
Dimer 
D 
1st 3 1 6 3 
2nd 3 0 2 0 
3rd 3 1 2 3 
     
claudin-2 
Dimer 
A 
Dimer 
B 
Dimer 
C 
Dimer 
D 
1st 7 0 10 2 
2nd 9 0 6 1 
3rd 7 0 6 2 
     
claudin-5 
Dimer 
A 
Dimer 
B 
Dimer 
C 
Dimer 
D 
1st 9 6 2 0 
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2nd 8 2 4 2 
3rd 8 1 3 1 
     
claudin-15 
Dimer 
A 
Dimer 
B 
Dimer 
C 
Dimer 
D 
1st 12 0 3 1 
2nd 8 0 3 1 
3rd 12 0 3 2 
     
Percentage 
Dimer 
A 
Dimer 
B 
Dimer 
C 
Dimer 
D 
claudin-1 33.33% 7.41% 37.04% 22.22% 
claudin-2 46.00% 0.00% 44.00% 10.00% 
claudin-5 54.35% 19.57% 19.57% 6.52% 
claudin-15 71.11% 0.00% 20.00% 8.89% 
 
Dimer type count and percentage calculation from 10 repeat non-mutated 
and mutated self-assembly simulations 
Non-mutated Claudin-5 
Time Dimer A Dimer B Dimer C Dimer D 
1 9 6 2 0 
2 8 2 4 2 
3 8 1 3 1 
4 10 1 1 1 
5 10 1 0 0 
6 9 1 2 1 
7 8 0 2 2 
8 7 3 4 2 
9 7 1 2 1 
10 9 0 1 0 
 
 
Muted Claudin-5 
Time Dimer A Dimer B Dimer C Dimer D 
1 4 0 1 3 
2 4 2 2 1 
3 10 1 2 0 
4 4 0 3 2 
5 8 1 4 2 
6 9 2 1 4 
7 3 1 1 3 
8 12 1 4 2 
9 4 2 1 2 
10 9 0 1 3 
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Average Number Dimer A Dimer B Dimer C Dimer D 
Non-mutated 8.5 1.6 2.1 1 
Mutated 6.7 1 2 2.2 
 
Ratio Dimer A Dimer B Dimer C Dimer D 
Non-mutated 64.39% 12.12% 15.91% 7.58% 
Mutated 56.30% 8.40% 16.81% 18.49% 
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